A Human Cytome Project - References

A human cytome project aims at creating a better understanding of a cellular level of biological complexity in order to allow us to close the gap between (our) molecules and the intrahuman ecosystem. Understanding the (heterogeneous) cellular level of biological organisation and complexity is (almost) within reach of present day science, which makes such a project ambitious but achievable. A human cytome project is about creating a solid translational science, not from bench to bedside, but from molecule to man.

References

• Abraham VC, Taylor DL, Haskins JR., High content screening applied to large-scale cell biology, Trends Biotechnol. 2004 Jan;22(1):15-22.
• Achenbach TV, Brunner B, Heermeier K., Oligonucleotide-based knockdown technologies: antisense versus RNA interference, Chembiochem. 2003 Oct 6;4(10):928-35..
• Adams MC, Salmon WC, Gupton SL, Cohan CS, Wittmann T, Prigozhina N, Waterman-Storer CM., A high-speed multispectral spinning-disk confocal microscope system for fluorescent speckle microscopy of living cells, Methods. 2003 Jan; 29(1):29-41.
• Aitchison J.D, Galitski, T., Inventories to insights, The Journal of Cell Biology 2003; 161:3, 465�469.
• Alanine A, Nettekoven M, Roberts E, Thomas AW., Lead generation--enhancing the success of drug discovery by investing in the hit to lead process, Comb Chem High Throughput Screen. 2003 Feb; 6(1):51-66.
• Albert JM, Demets DL., On a model-based approach to estimating efficacy in clinical trials, Stat Med 1994 Nov;13(22):2323-2335.
• Alexander, S., Hellemans, L., Marti, O., Schneir, J., Elings, V., Hansma, P.K., Longmiro, M., and Gurley, J., An atomic-resolution atomic-force microscope implemented using an optical lever. J. Appl. Phys. 1989, 65(1), 164-167
• Alivisatos, A. P., The Use of Nanocrystals in Biological Detection, Nature Biotech. 2004, 22:47-52.
• Alwine JC, Kemp DJ, Stark GR., Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes, Proc Natl Acad Sci U S A. 1977 Dec;74(12):5350-4.
• Alwine JC, Kemp DJ, Parker BA, Reiser J, Renart J, Stark GR, Wahl GM, Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper, Methods Enzymol. 1979; 68:220-42.
• Andrews PD, Harper IS, Swedlow JR., To 5D and beyond: quantitative fluorescence microscopy in the postgenomic era, Traffic. 2002 Jan; 3(1):29-36.
• Apic G, Ignjatovic T, Boyer S, Russell RB., Illuminating drug discovery with biological pathways, FEBS Lett. 2005 Mar 21;579(8):1872-7.
• Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S, Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature. 2004 Oct 14;431(7010):805-10.
• Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C, Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms, Hum Mutat. 2004 Apr;23(4):343-57.
• Autumn A. Cuellar, Poul F. Nielsen, David P. Bullivant, and Peter J. Hunter, CellML 1.1 for the Definition and Exchange of Biological Models. Conf. Proc. 2003 IFAC Symposium on Modelling and Control in Biomedical Systems. 2003 Nov; 451-456.
• Ayoubi TA, Van De Ven WJ, Regulation of gene expression by alternative promoters, FASEB J. 1996 Mar;10(4):453-60.
• Bacskai BJ, Hickey GA, Skoch J, Kajdasz ST, Wang Y, Huang GF, Mathis CA, Klunk WE, Hyman BT., Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice, Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12462-7. Epub 2003 Sep 29.
• Bader JS., The relative power of SNPs and haplotype as genetic markers for association tests, Pharmacogenomics. 2001 Feb; 2(1):11-24.
• Baghdoyan S, Roupioz Y, Pitaval A, Castel D, Khomyakova E, Papine A, Soussaline F, Gidrol X., Quantitative analysis of highly parallel transfection in cell microarrays, Nucleic Acids Res. 2004 May 21;32(9):e77.
• Bailey DG, Spence JD, Munoz C, Arnold JM., Interaction of citrus juices with felodipine and nifedipine, Lancet. 1991 Feb 2;337(8736):268-9.
• Bailey SN, Wu RZ, Sabatini DM., Applications of transfected cell microarrays in high-throughput drug discovery, Drug Discov Today. 2002 Sep 15;7(18 Suppl):S113-8.
• Baksh D, Song L, Tuan RS., Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy, Cell Mol Med. 2004 Jul-Sep; 8(3):301-16.
• Banan M, Puri N., The ins and outs of RNAi in mammalian cells, Curr Pharm Biotechnol. 2004 Oct; 5(5):441-50.
• Barbieri RL, Gao X, 17 beta-Hydroxysteroid dehydrogenase: enzymatic activity and mRNA species in choriocarcinoma cells, Gynecol Obstet Invest. 1994;37(3):210-4.
• Barker J, Garner RC., Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom, Rapid Commun Mass Spectrom. 1999;13(4):285-93.
• Barroso I, et al., Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature. 1999 Dec 23-30;402(6764):880-3.
• Bassingthwaighte JB., Toward modeling the human physionome, Adv Exp Med Biol. 1995; 382:331-9.
• Bassingthwaighte JB., Strategies for the physiome project, Ann Biomed Eng. 2000 Aug; 28(8):1043-58.
• Bassoe C.F., Li N, Ragheb K, Lawler G, Sturgis L, J. , Robinson P.J., Cytometric Investigations of Phagosomes, Mitochondria and Acidic Granules in Human neutrophils, Cytometry 2003 Jan;51B(1):21-9.
• Bayer voluntarily withdraws Baycol, AWHONN Lifelines. 2001 Oct-Nov;5(5):21.
• Benson ES., Leukemia and the Philadelphia chromosome, Postgrad Med. 1961 Dec;30:A22-A28.
• Berends M., Maex R., De Schutter E., A detailed three-dimensional model of the cerebellar granular layer, Neurocomputing 2004, 58-60, 587-592.
• Berg EL, Hytopoulos E, Plavec I, Kunkel EJ., Approaches to the analysis of cell signaling networks and their application in drug discovery, Curr Opin Drug Discov Devel. 2005 Jan; 8(1):107-14.
• Berger A, Drosten Ch, Doerr HW, Sturmer M, Preiser W, Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection, J Clin Virol. 2004 Jan; 29(1):13-22.
• Berger EG., Ectopic localizations of Golgi glycosyltransferases., Glycobiology. 2002 Feb; 12(2):29R-36R.
• Bergstrom M, Grahnen A, Langstrom B., Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development, Eur J Clin Pharmacol. 2003 Sep;59(5-6):357-66. Epub 2003 Aug 22.
• Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R., A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature. 2004 Mar 25; 428(6981):431-7.
• Berridge MJ., The endoplasmic reticulum: a multifunctional signaling organelle, Cell Calcium. 2002 Nov-Dec;32(5-6):235-49.
• Berridge MJ., Phosphatidylinositol hydrolysis and calcium signalling, Adv Cyclic Nucleotide Res. 1981;14:289-99.
• Berridge MJ., Cardiac calcium signalling, Biochem Soc Trans. 2003 Oct;31(Pt 5):930-3.
• Berridge MJ, Bootman MD, Roderick HL., Calcium signalling: dynamics, homeostasis and remodelling, Nat Rev Mol Cell Biol. 2003b Jul;4(7):517-29.
• Berridge MJ., Unlocking the Secrets of Cell Signaling, Annu Rev Physiol. 2004 Jul 16.
• Bers DM., Dynamic imaging in living cells: windows into local signalling, Sci STKE. 2003 Apr 8; 2003(177):PE13. Print 2003 Apr 8.
• Betz UA, Farquhar R, Ziegelbauer K., Genomics: success or failure to deliver drug targets?, Curr Opin Chem Biol. 2005 Aug;9(4):387-91.
• Bjornsson HT, Fallin MD, Feinberg AP., An integrated epigenetic and genetic approach to common human disease, Trends Genet. 2004 Aug;20(8):350-8.
• Bila V, Kren V., The significance of genetic factors for thalidomide teratogenicity in the Norway rat, Acta Univ Carol [Med] (Praha). 1989;35(1-2):3-10.
• Bilello JA., The agony and ecstasy of "OMIC" technologies in drug development, Curr Mol Med. 2005 Feb;5(1):39-52.
• Blair JE, Evaluation of fever in the international traveler. Unwanted 'souvenir' can have many causes, Postgrad Med. 2004 Jul;116(1):13-20, 29.
• Bleicher KH, Bohm HJ, Muller K, Alanine AI., Hit and lead generation: beyond high-throughput screening, Nat Rev Drug Discov. 2003 May;2(5):369-78.
• Bohets H, Annaert P, Mannens G, Van Beijsterveldt L, Anciaux K, Verboven P, Meuldermans W, Lavrijsen K., Strategies for absorption screening in drug discovery and development, Curr Top Med Chem. 2001 Nov;1(5):367-83.
• Bootman MD, Collins TJ, Peppiatt CM, Prothero LS, MacKenzie L, De Smet P, Travers M, Tovey SC, Seo JT, Berridge MJ, Ciccolini F, Lipp P., Calcium signalling--an overview, Semin Cell Dev Biol. 2001 Feb;12(1):3-10.
• Bootman MD, Berridge MJ, Roderick HL., Calcium signalling: more messengers, more channels, more complexity, Curr Biol. 2002 Aug 20;12(16):R563-5.
• Borgers M, Thone F, Ver Donck L., Sarcolemma-bound calcium. Its importance for cell viability, Basic Res Cardiol. 1985; 80 Suppl 1:30-5.
• Borgers M, Ver Donck L, Vandeplassche G., Pathophysiology of cardiomyocytes, Ann N Y Acad Sci. 1988; 522:433-53.
• Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG., Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice, Genes Brain Behav. 2004 Jun;3(3):149-57.
• Braet F, de Zanger R, Seynaeve C, Baekeland M, Wisse E., A comparative atomic force microscopy study on living skin fibroblasts and liver endothelial cells, J Electron Microsc (Tokyo). 2001;50(4):283-90.
• Braunschweig T, Chung JY, Hewitt SM., Perspectives in tissue microarrays, Comb Chem High Throughput Screen. 2004 Sep;7(6):575-85.
• Bright GR, Fisher GW, Rogowska J, Taylor DL, Fluorescence ratio imaging microscopy, Methods Cell Biol. 1989;30:157-92.
• Butcher EC., Can cell systems biology rescue drug discovery?, Nat Rev Drug Discov. 2005 Jun;4(6):461-7. Review.
• Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G., Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives, Health Technol Assess. 2001; 5(33):1-56.
• Broussard LA, Biological agents: weapons of warfare and bioterrorism, Mol Diagn. 2001 Dec;6(4):323-33.
• Brown K, Tompkins EM, White IN., Applications of accelerator mass spectrometry for pharmacological and toxicological research, Mass Spectrom Rev. 2006 Jan-Feb;25(1):127-45.
• Brusa R., Genetically modified mice in neuropharmacology, Pharmacol Res. 1999 Jun; 39(6):405-19.
• Burger A., Drug design and development. A realistic appraisal, J Med Chem. 1978 Jan;21(1):1-4.
• Butcher EC, Berg EL, Kunkel EJ., Systems biology in drug discovery, Nat Biotechnol. 2004 Oct; 22(10):1253-9.
• Byng MC, Whittaker JC, Cuthbert AP, Mathew CG, Lewis CM., SNP subset selection for genetic association studies, Ann Hum Genet. 2003 Nov;67(Pt 6):543-56.
• Cahana A, Mauron A., The story of Vioxx-- no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry, J Anesth. 2006;20(4):348-51.
• Caceres M, Lachuer J, Zapala MA, Redmond JC, Kudo L, Geschwind DH, Lockhart DJ, Preuss TM, Barlow C, Elevated gene expression levels distinguish human from non-human primate brains, Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13030-5.
• Cajiao I, Zhang A, Yoo EJ, Cooke NE, Liebhaber SA., Bystander gene activation by a locus control region, EMBO J. 2004 Sep 29; 23(19):3854-63.
• Caldwell GW, Ritchie DM, Masucci JA, Hageman W, Yan Z., The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery, Curr Top Med Chem. 2001 Nov;1(5):353-66.
• Caldwell G.W., Compound Optimization in Early and Late Phase Drug Discovery: Acceptable Pharmacokinetic Properties Utilizing Combined Physicochemical, In Vitro and In Vivo Screens, Frontiers in Medicinal Chemistry - Online, Volume 1, Number 1, January 2004, pp. 607-618(12).
• Cancela JM, Van Coppenolle F, Galione A, Tepikin AV, Petersen OH., Transformation of local Ca²⁺ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca²⁺ releasing messengers, EMBO J. 2002 Mar 1;21(5):909-19.
• Capecchi MR., Altering the genome by homologous recombination, Science. 1989 Jun 16;244(4910):1288-92.
• Capua I, Alexander DJ, Avian influenza: recent developments, Avian Pathol. 2004 Aug; 33(4):393-404.
• Carey G., Genetic association study in psychiatry: analytical evaluation and a Recommendation, Am J Med Genet. 1994 Dec 15;54(4):311-7.
• Carrington WA, Lisin D., Cluster computing for digital microscopy, Microsc Res Tech. 2004 Jun 1; 64(2):204-13.
• Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC., Green fluorescent protein as a marker for gene expression, Science. 1994 Feb 11; 263(5148):802-5.
• Chambers G, Lawrie L, Cash P, Murray GI, Proteomics: a new approach to the study of disease, J Pathol. 2000 Nov; 192(3):280-8.
• Chan SW, Zilberman D, Xie Z, Johansen LK, Carrington JC, Jacobsen SE., RNA silencing genes control de novo DNA methylation, Science. 2004 Feb 27; 303(5662):1336.
• Chan WC, Nie S., Quantum dot bioconjugates for ultrasensitive nonisotopic detection, Science. 1998 Sep 25; 281(5385):2016-8.
• Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S., Luminescent quantum dots for multiplexed biological detection and imaging, Curr Opin Biotechnol. 2002 Feb; 13(1):40-6.
• Chapman JM, Cooper JD, Todd JA, Clayton DG., Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power, Hum Hered. 2003;56(1-3):18-31.
• Chen, X., Velliste, M., Weinstein, S., Jarvik, J.W., and Murphy, R.F., Location proteomics-Building subcellular location tree from high resolution 3D fluorescence microcope images of randomly-tagged proteins. Manipulation and Analysis of Biomolecules, Cells, and Tissues, Proceedings of SPIE 2003; 4962: 298�306.
• Chien JY, Friedrich S, Heathman MA, de Alwis DP, Sinha V., Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation, AAPS J. 2005 Oct 7;7(3):E544-59.
• Chiu SH, Huskey SW., Species differences in N-glucuronidation, Drug Metab Dispos. 1998 Sep;26(9):838-47.
• Cho, M.J., Thompson, D.P., Cramer, C.T., Vidmar, T.J. and Scieszka, J.F (1989). The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier, Pharmaceutical Research 6: 71-77
• Chong S, Whitelaw E, Epigenetic germline inheritance, Curr Opin Genet Dev. 2004 Dec; 14(6):692-6.
• Choy G, O'Connor S, Diehn FE, Costouros N, Alexander HR, Choyke P, Libutti SK., Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging, Biotechniques. 2003 Nov;35(5):1022-6, 1028-30.
• Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, Sexton PM., Novel receptor partners and function of receptor activity-modifying proteins, J Biol Chem. 2003 Jan 31; 278(5):3293-7. Epub 2002 Nov 21.
• Citron M., Strategies for disease modification in Alzheimer's disease, Nat Rev Neurosci. 2004 Sep; 5(9):677-85.
• Clayton AJ, Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada?, Can Med Assoc J. 1979 Jan 20;120(2):146-55.
• Claverie J.-M., Gene Number. What If There Are Only 30,000 Human Genes?, Science 2001; 291: 1255�7.
• Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ., An introduction to critical paths, Qual Manag Health Care. 1992 Fall;1(1):45-54.
• Cole, N. B. et al., Diffusional mobility of Golgi proteins in membranes of living cells. Science 1996; �273, 797�801.
• Collins FS, Riordan JR, Tsui LC, The cystic fibrosis gene: isolation and significance, Hosp Pract (Off Ed). 1990 Oct 15;25(10):47-57.
• Collins F.S., Green E.S., Guttmacher A.E., Guyer M.S., A vision for the future of genomics research, Nature, 2003, 422:835-847
• Collins F.S., Morgan M, Patrinos A., Viewpoint: The Human Genome Project: Lessons from Large-Scale Biology. Science, 2003b, 300:286-290.
• Collins, F.S., International Human Genome Sequencing Consortium, Finishing the euchromatic sequence of the human genome, Nature 2004, 431, 931 � 945.
• Conrad C, Erfle H, Warnat P, Daigle N, Lorch T, Ellenberg J, Pepperkok R, Eils R, Automatic identification of subcellular phenotypes on human cell Arrays, Genome Res. 2004 Jun;14(6):1130-6.
• Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA., Visualizing gene expression in living mammals using a bioluminescent reporter, Photochem Photobiol. 1997 Oct;66(4):523-31.
• Cornelissen, F., Wouters, L., Ver Donck, L., Verellen, G., Geerts, H., Automatic quantification of the effect of cardioprotective drugs in isolated myocytes, Bioimaging, 1993,� 1, 197-206.
• Cornelussen RN, Ver Donck L, Verellen G, Borgers M, van der Vusse GJ, Reneman RS, Snoeckx LH., Calcium homeostasis in cardiomyocytes isolated from heat-shocked rats, Am J Physiol. 1996 Nov;271(5 Pt 2):H1938-46.
• Cozens DD., Abnormalities of the external form and of the skeleton in the New Zealand white rabbit, Food Cosmet Toxicol. 1965 Nov-Dec;3(5):695-700.
• Craig JM., Heterochromatin--many flavours, common themes, Bioessays. 2005 Jan; 27(1):17-28.
• Crawford L.M., D.V.M., Ph.D., Acting Commissioner of the FDA, Speech for Banc of America Securities Healthcare Institutional Investor Conference, 7 July 2004.
• Crawford M, Woodman R, Ko Ferrigno P., Peptide aptamers: tools for biology and drug discovery, Brief Funct Genomic Proteomic. 2003 Apr;2(1):72-9.
• Cremer T, Kupper K, Dietzel S, Fakan S., Higher order chromatin architecture in the cell nucleus: on the way from structure to function, Biol Cell. 2004 Oct;96(8):555-67.
• Crentsil V., The pharmacogenomics of Alzheimer's disease, Ageing Res Rev. 2004 Apr;3(2):153-69.
• Crick, F.H.C., Codon-Anticodon Pairing: The Wobble Hypothesis, J. Mol. Biol. 1966, 19:548-555.
• Crosthwaite SK., Circadian clocks and natural antisense RNA, FEBS Lett. 2004 Jun 1; 567(1):49-54.
• Crusio WE., Flanking gene and genetic background problems in genetically manipulated mice, Biol Psychiatry. 2004 Sep 15;56(6):381-5.
• Cullen BR., Transcription and processing of human microRNA precursors, Mol Cell. 2004 Dec 22; 16(6):861-5.
• Czermin B, Imhof A., The sounds of silence--histone deacetylation meets histone methylation, Genetica. 2003 Mar; 117(2-3):159-64.
• Danuser G, Waterman-Storer CM., Quantitative fluorescent speckle microscopy: where it came from and where it is going, J Microsc. 2003 Sep;211(Pt 3):191-207.
• Darvasi A., Experimental strategies for the genetic dissection of complex traits in animal models, Nat Genet. 1998 Jan; 18(1):19-24.
• Darvasi A, Pisante-Shalom A., Complexities in the genetic dissection of quantitative trait loci, Trends Genet. 2002 Oct; 18(10):489-91.
• Davidson MH., Controversy surrounding the safety of cerivastatin, Expert Opin Drug Saf. 2002 Sep;1(3):207-12.
• Davie C, Pierre-Valentin J, Pollard C, Standen N, Mitcheson J, Alexander P, Thong B., Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel, J Cardiovasc Electrophysiol. 2004 Nov;15(11):1302-9.
• Davies J, New pathogens and old resistance genes, Microbiologia. 1994 Mar-Jun;10(1-2):9-12.
• Davies E, Stankovic B, Azama K, Shibata K, Abe S., Novel components of the plant cytoskeleton: A beginning to plant "cytomics",� Plant Science, Invited Review, Plant Science 2001; (160)2: 185-196.
• Day R, Beck DA, Armen RS, Daggett V., A consensus view of fold space: combining SCOP, CATH, and the Dali Domain Dictionary, Protein Sci. 2003 Oct;12(10):2150-60.
• Dean M, et al., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996, 273: 1856-1862.
• Dean P., Mascio L., Ow D., Sudar D., Mullikin J., Proposed standard for image cytometry data files, Cytometry, 1990; 11:561-569.
• De Brabander M, De Mey J, Joniau M, Geuens S, Immunocytochemical visualization of microtubules and tubulin at the light- and electron-microscopic level, J Cell Sci. 1977 Dec;28:283-301.
• De Brabander M, Nuydens R, Geuens G, Moeremans M, De Mey J, The use of submicroscopic gold particles combined with video contrast enhancement as a simple molecular probe for the living cell, Cell Motil Cytoskeleton. 1986; 6(2):105-13.
• De Brabander M, Geuens G, Nuydens R, Moeremans M, De Mey J., Microtubule-dependent intracellular motility investigated with nanometer particle video ultramicroscopy (nanovid ultramicroscopy), Ann N Y Acad Sci. 1986b;466:666-8.
• De Brabander M, Geerts H, Nuydens R, Nuyens R., Detection of gold probes with video-enhanced contrast microscopy: nanovid microscopy, Am J Anat. 1989 Jun-Jul;185(2-3):282-95.�
• Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K, Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients, Eur Respir J. 2004 May;23(5):679-84.
• De Duve C, Pressman B C, Gianetto R, Wattiaux R and Appelmans F., Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochemical Journal 1955, 60:604-17.
• De Duve, Wattiaux R., Functions of lysosomes, Annu. Rev. Physiol. 1966; 28:435-492.
• de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR., A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia, Nature. 1982 Dec 23;300(5894):765-7.
• Delahunt CS, Lassen LJ., Thalidomide syndrome in monkeys, Science 1964 Dec 4;146:1300-5
• De Mey J, Hoebeke J, De Brabander M, Geuens G, Joniau M, Immunoperoxidase visualisation of microtubules and microtubular proteins, Nature 1976 Nov 18; 264(5583):273-5.
• De Mey, J., Moeremans, M., Geuens, G., Nuydens, R., De Brabander, M., High resolution light and electron microscopic localization of tubulin with the IGS (immuno-gold staining) method, Cell Biol. Int. Rep. 1981, 5, 889-899.
• De Ridder F., Predicting the outcome of phase III trials using phase II data: a case study of clinical trial simulation in late stage drug development, Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):235-41.
• DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM, Use of a cDNA microarray to analyse gene expression patterns in human cancer, Nat Genet. 1996 Dec;14(4):457-60.
• Deuschle K, Fehr M, Hilpert M, Lager I, Lalonde S, Looger LL, Okumoto S, Persson J, Schmidt A, Frommer WB, Genetically encoded sensors for metabolites, Cytometry A. 2005 Mar; 64A(1):3-9.
• Dickson M, Gagnon JP., Key factors in the rising cost of new drug discovery and development, Nat Rev Drug Discov. 2004 May;3(5):417-29.
• Dietmann S, Holm L., Identification of homology in protein structure classification, Nat Struct Biol. 2001 Nov;8(11):953-7.
• DiMasi, J.A., Risks, Regulation, and Rewards in New Drug Development in the United States, Regulatory Toxicology and Pharmacology, 1994, Vol. 19.
• DiMasi J.A., New drug development in the United States 1963-1999, Clin Pharmacol Ther, 69:286-296.
• DiMasi J.A., Risks in new drug development: approval success rates for investigational drugs, Clin Pharmacol Ther, 69:297-307.
• DiMasi J.A., Hansen RW, Grabowski HG., The price of innovation: new estimates of drug development costs, J Health Econ. 2003 Mar;22(2):325-30.
• De Schutter E., Computational Neuroscience: Trends in research 2004, (Guest editorial), Neurocomputing 2004, 58-60, xix-xxi
• Di L, Kerns EH., Application of pharmaceutical profiling assays for optimization of drug-like properties, Curr Opin Drug Discov Devel. 2005 Jul;8(4):495-504.
• Dimitrova D. S., Berezney R., The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells, Journal of Cell Science 115, 4037-4051 (2002).
• Dockray GJ., The biosynthesis of regulatory peptides, Am Rev Respir Dis. 1987 Dec; 136(6 Pt 2):S9-15.
• Doria A., Methods for the study of the genetic determinants of diabetes and its complications, Przegl Lek. 2000; 57 Suppl 3:7-12.
• Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A., Embryonic stem cells: a promising tool for cell replacement therapy, J Cell Mol Med. 2004 Oct-Dec;8(4):465-73.
• Dulbecco R., A turning point in cancer research: Sequencing the genome, Science, 1986, 231: 1055-56.
• Dracopoli NC., Pharmacogenomic applications in clinical drug development, Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S57-60. Epub 2003 Jun 18.
• Drake B, Prater CB, Weisenhorn AL, Gould SA, Albrecht TR, Quate CF, Cannell DS, Hansma HG, Hansma PK., Imaging crystals, polymers, and processes in water with the atomic force microscope, Science. 1989 Mar 24;243(4898):1586-9.
• Drews J, Drug Discovery: A Historical Perspective, Science 17 March 2000; 287: 1960-1964
• Drews, J., In Quest of Tomorrows Medicines, Springer-Verlag, 1999.
• Drucker-Colin R, Verdugo-Diaz L., Cell transplantation for Parkinson's disease: present status, Cell Mol Neurobiol. 2004 Jun;24(3):301-16.
• Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB., Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells, Nat Med. 1996 May;2(5):561-6.
• Druker BJ, Lydon NB., Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia, J Clin Invest. 2000 Jan;105(1):3-7..
• Duesberg P., Rausch C., Rasnick D., Hehlmann R., Genetic instability of cancer cells is proportional to their degree of aneuploidy, Proc Natl Acad Sci U S A. 1998 November 10; 95 (23): 13692-13697.
• Duesberg P, Fabarius A, Hehlmann R., Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells, IUBMB Life. 2004 Feb;56(2):65-81.
• Dundr M, McNally JG, Cohen J, Misteli T., Quantitation of GFP-fusion proteins in single living cells, J Struct Biol. 2002 Oct-Dec;140(1-3):92-9.
• Dupuy D, Li QR, Deplancke B, Boxem M, Hao T, Lamesch P, Sequerra R, Bosak S, Doucette-Stamm L, Hope IA, Hill DE, Walhout AJ, Vidal M, A first version of the Caenorhabditis elegans Promoterome, Genome Res. 2004 Oct; 14(10B):2169-75.
• Dyer C., UK patients seek compensation after taking rofecoxib, BMJ. 2004 Dec 4;329(7478):1308.
• Dzhambazov B, Teneva I, Koleva L, Asparuhova D, Popov N., Morphological, genetic and functional variability of a T-cell hybridoma line, Folia Biol (Praha). 2003;49(2):87-94.
• Eakin, Hugh, Bayer Says Baycol Costs May Exceed Its Insurance, New York Times, March 14, 2003.
• Ecker RC, de Martin R, Steiner GE, Schmid JA, Application of spectral imaging microscopy in cytomics and fluorescence resonance energy transfer (FRET) analysis, Cytometry,� 2004 Jun;59A(2):172-81.
• Ecker RC, Steiner GE., Microscopy-based multicolor tissue cytometry at the single-cell level, Cytometry. 2004b Jun;59A(2):182-90.
• Edland SD, Slager S, Farrer M., Genetic association studies in Alzheimer's disease research: challenges and opportunities, Stat Med. 2004 Jan 30;23(2):169-78.
• Edlund, H.: Transcribing Pancreas. Diabetes, 1998; 47:1817-1823
• Edwards BS, Oprea T, Prossnitz ER, Sklar LA., Flow cytometry for high-throughput, high-content screening, Curr Opin Chem Biol. 2004 Aug;8(4):392-8.
• Egner, A., Verrier S., Goroshkov A., S�ling H.-D., Hell S. W., 4Pi-microscopy of the Golgi apparatus in live mammalian cells, J. Struct. Biol. 2004; 147(1): 70-76.
• Eikelenboom P, van Gool WA., Neuroinflammatory perspectives on the two faces of Alzheimer's disease, J Neural Transm. 2004 Mar;111(3):281-94. Epub 2003 Dec 03.
• Eils R, Athale C., Computational imaging in cell biology, J Cell Biol. 2003 May 12;161(3):477-81.
• Ekker SC., Morphants: a new systematic vertebrate functional genomics approach, Yeast. 2000 Dec;17(4):302-306..
• Elkin S, Geddes D., Pseudomonal infection in cystic fibrosis: the battle continues, Expert Rev Anti Infect Ther. 2003 Dec;1(4):609-18.
• Ellenberg, J., et al. Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J. Cell Biol. 1997; 138, 1193�1206.
• Ellington AD, Szostak JW, In vitro selection of RNA molecules that bind specific ligands., Nature, 1990 Aug 30;346(6287):818-22.
• Ellis C., Nature Reviews Drug Discovery GPCR Questionnaire Participants., The state of GPCR research in 2004., Nat Rev Drug Discov. 2004 Jul; 3(7):575, 577-626.
• El-Osta A., Understanding the Consequences of Epigenetic Mechanisms and Its Effects on Transcription in Health and Disease, Cancer Biol Ther. 2004 Sep 23;3(9).
• Emptage NJ., Fluorescent imaging in living systems, Curr Opin Pharmacol. 2001 Oct;1(5):521-5.
• Entzeroth M, Emerging trends in high-throughput screening, Curr Opin Pharmacol. 2003 Oct;3(5):522-9.
• Eckhardt F, Beck S, Gut IG, Berlin K, Future potential of the Human Epigenome Project, Expert Rev Mol Diagn. 2004 Sep;4(5):609-18.
• Erickson RP., Mouse models of human genetic disease: which mouse is more like a man?, Bioessays. 1996 Dec; 18(12):993-8.
• Eungdamrong NJ, Iyengar R., Modeling cell signaling networks, Biol Cell. 2004 Jun; 96(5):355-62.
• Evans MJ, Kaufman MH., Establishment in culture of pluripotential cells from mouse embryos, Nature 1981; 292: 154�156.
• Fajans SS, Bell GI, Polonsky KS, Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young, N Engl J Med. 2001 Sep 27;345(13):971-80.
• Fan GY, Fujisaki H, Miyawaki A, Tsay RK, Tsien RY, Ellisman MH., Video-rate scanning two-photon excitation fluorescence microscopy and ratio imaging with cameleons, Biophys J. 1999 May;76(5):2412-20
• Fauci AS, Host factors and the pathogenesis of HIV-induced disease, Nature 1996, 384: 529-533.
• Fauci AS., Emerging infectious diseases: a clear and present danger to humanity, JAMA. 2004 Oct 20; 292(15):1887-8.
• Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B., Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials, BMJ. 2005 Feb 19;330(7488):396.
• Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature 1998; 391:806 � 811.
• Fischer JA, Muff R, Born W., Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs), Biochem Soc Trans. 2002 Aug; 30(4):455-60.
• Fitzgerald GA., Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics, Nat Rev Drug Discov. 2005 Oct;4(10):815-8..
• Fleming, A, On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae, The British Journal of Experimental Pathology, 1929; Vol. X, 226-236.
• Foord SM., Matching accessories, Sci STKE. 2003 Jul 08; 2003(190):pe25.
• Ford D, et al., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium, Am J Hum Genet. 1998 Mar; 62(3):676-89.
• Fortna A, Kim Y, MacLaren E, Marshall K, Hahn G, Meltesen L, Brenton M, Hink R, Burgers S, Hernandez-Boussard T, Karimpour-Fard A, Glueck D, McGavran L, Berry R, Pollack J, Sikela JM., Lineage-specific gene duplication and loss in human and great ape evolution, PLoS Biol. 2004 Jul; 2(7):E207. Epub 2004 Jul 13.
• Fowler BA., Molecular biomarkers: Challenges and prospects for the future, Toxicol Appl Pharmacol. 2005 Aug 7;206(2):97.
• Frank RE, Bartholomew DW, Cystic fibrosis--a genetic dilemma, J Insur Med. 2004; 36(2):158-61.
• Fraser A., Towards full employment: using RNAi to find roles for the redundant, Oncogene. 2004 Nov 1; 23(51):8346-52.
• Frodsham AJ, Hill AV., Genetics of infectious diseases, Hum Mol Genet. 2004 Oct 1; 13 Spec No 2:R187-94.
• Fry JR., The metabolism of drugs by isolated hepatocytes, Q Rev Drug Metab Drug Interact. 1982;4(2-3):99-122.
• Fuhr U., Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance, Drug Saf. 1998 Apr;18(4):251-72.
• Furberg CD, Pitt B., Withdrawal of cerivastatin from the world market, Curr Control Trials Cardiovasc Med. 2001;2(5):205-207.
• Garcia-Otin AL, Guillou F., Mammalian genome targeting using site-specific recombinases, Front Biosci. 2006 Jan 1;11:1108-36.
• Garner C, Slatkin M., On selecting markers for association studies: patterns of linkage disequilibrium between two and three diallelic loci, Genet Epidemiol. 2003 Jan; 24(1):57-67.
• Gattei V, Aldinucci D, Petti MC, Da Ponte A, Zagonel V, Pinto A., In vitro and in vivo effects of 5-aza-2'-deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients, Leukemia. 1993 May; 7 Suppl 1:42-8.
• Gaush, C.R., Hard, W.L. and Smith, T.E., Characterization of an established line of canine kidney cells (MDCK), Proceedings of the Society for Experimental Biology and Medicine. 1966 122: 931-935
• Gautier S, Bachelet H, Bordet R, Caron J., The cost of adverse drug reactions, Expert Opin Pharmacother. 2003 Mar;4(3):319-26.
• Geerts H, De Brabander M, Nuydens R, Geuens S, Moeremans M, De Mey J, Hollenbeck P., Nanovid tracking: a new automatic method for the study of mobility in living cells based on colloidal gold and video microscopy, Biophys J. 1987 Nov; 52(5):775-82.
• Geerts H, Nuydens R, Nuyens R, Ver Donck L., The effect of flunarizine on intracellular calcium in isolated rat cardiomyocytes, A digital image processing study, Cardiovasc Res. 1989 Sep;23(9):797-806, Erratum in: Cardiovasc Res 1989 Nov; 23(11):992.
• Geerts H, de Brabander M, Nuydens R, Nanovid microscopy, Nature. 1991 Jun; 27;351(6329):765-6.
• Geerts, H., Nuydens, R., Nuyens, R., Cornelissen, F., Quantification of fast axonal transport by video microscopy, Methods in Neurosciences, 1992; 10, p.297-314.
• Geerts H, Nuydens R, De Jong M, Cornelissen F, Nuyens R, Wouters L., Sabeluzole stabilizes the neuronal cytoskeleton, Neurobiol Aging. 1996; Jul-Aug;17(4):573-81.
• Gehan EA, Schneiderman MA., Historical and methodological developments in clinical trials at the National Cancer Institute, Stat Med. 1990 Aug;9(8):871-80; discussion 903-6.
• George SR, O'Dowd BF, Lee SP., G-protein-coupled receptor oligomerization and its potential for drug discovery, Nat Rev Drug Discov. 2002 Oct; 1(10):808-20.
• George TC, Basiji DA, Hall BE, Lynch DH, Ortyn WE, Perry DJ, Seo MJ, Zimmerman CA, Morrissey PJ, Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer, Cytometry, 2004: Jun;59A(2):237-45.
• Georgiou-Karistianis N, Smith E, Bradshaw JL, Chua P, Lloyd J, Churchyard A, Chiu E., Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease, Brain Res Bull. 2003 Jan 30;59(5):331-8.
• Gerard E, Infectious diseases in air travellers arriving in the UK, J R Soc Health. 2002 Jun;122(2):86-8.
• Gerlich D, Mattes J, Eils R., Quantitative motion analysis and visualization of cellular structures, Methods. 2003 Jan;29(1):3-13.
• Gerlich D, Ellenberg J., 4D imaging to assay complex dynamics in live specimens, Nat Cell Biol. 2003b Sep;Suppl:S14-9.
• Gerster AO, Trumpfheller C, Racz P, Osmancik P, Tenner-Racz K, Tarnok A., Quantitative histology by multicolor slide-based cytometry, Cytometry. 2004 Oct;61A(2):210-9.
• Geuens G, Gundersen GG, Nuydens R, Cornelissen F, Bulinski JC, DeBrabander M, Ultrastructural colocalization of tyrosinated and detyrosinated alpha-tubulin in interphase and mitotic cells, J Cell Biol. 1986 Nov;103(5):1883-93.
• Geusebroek J.M., Cornelissen F., Smeulders A. W. M., Geerts H., Robust autofocusing in microscopy, Cytometry 2000, 39(1):1-9.
• Geusebroek J.M., van den Boomgaard R., Smeulders A.W.M., Geerts H., Color invariance, IEEE Trans. Pattern Anal. Machine Intell., 2001; 23(12):1338-1350.
• Geusebroek J. M., van den Boomgaard R., Smeulders A. W. M., Gevers T., Color constancy from physical principles. Pat. Rec. Let. 2003; 24(11):1653-1662.
• Geusebroek J. M., Smeulders A. W. M., van de Weijer J., Fast anisotropic gauss filtering, IEEE Trans. Image Processing 2003b; 12(8):938-943.
• Geusebroek J.M, Smeulders A. W. M., A six-stimulus theory for stochastic texture. Int. J. Comput. Vision April/May 2005; 62(1/2):7-16.
• Gey G.O., CoffmanW.D., Kubicek M.T, Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium, Cancer Res., 12: 264-265, 1952.
• Giavitto JL, Michel O., Modeling the topological organization of cellular processes, Biosystems. 2003 Jul;70(2):149-63..
• Gillen PB, Ebola and the filoviruses: reducing the threat by improving Third World medical care and education of aircrew members, Air Med J. 1999 Oct-Dec;18(4):156-9.
• Giuliano KA, Taylor DL., Fluorescent-protein biosensors: new tools for drug discovery, Trends Biotechnol. 1998 Mar; 16(3):135-40.
• Giuliano KA, Haskins JR, Taylor DL, Advances in high content screening for drug discovery, Assay Drug Dev Technol. 2003 Aug;1(4):565-77.
• Gobburu JV, Marroum PJ., Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making, Clin Pharmacokinet. 2001;40(12):883-92.
• Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH., Genetic transformation of mouse embryos by microinjection of purified DNA, Proc Natl Acad Sci U S A. 1980 Dec;77(12):7380-4.
• Gong JP, From genomics, proteomics to cytomics, or from cytometry to cytomics, Ai Zheng, 2003 May;22(5):449-51 (article in Chinese)
• Gottschalk R, Preiser W., Bioterrorism: is it a real threat?,Med Microbiol Immunol (Berl). 2004 Sep 2 (Epub)
• Goud B., Small GTP-binding proteins as compartmental markers, Semin Cell Biol. 1992 Oct; 3(5):301-7.
• Grabowski H, Vernon J, DiMasi JA, Returns on research and development for 1990s new drug introductions, Pharmacoeconomics. 2002;20 Suppl 3:11-29.
• Graham TR., Membrane targeting: getting Arl to the Golgi, Curr Biol. 2004 Jun 22; 14(12):R483-5.
• Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW., Challenges in the transition to model-based development, AAPS J. 2005 Oct 5;7(2):E488-95. .
• Greene LA, Tischler AS., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8.
• Griffin JP., Prepulsid withdrawn from UK and US markets, Adverse Drug React Toxicol Rev. 2000 Aug;19(3):177.
• Grody WW.,� Molecular genetic risk screening, Annu. Rev. Med. 2003, 54,473-490.
• Grunfeld GB., Modern medicine and the emergence of biomedical ethics, Caduceus. 1992 Spring;8(1):1-22.
• Gunnell D, Saperia J, Ashby D., Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review, BMJ. 2005 Feb 19;330(7488):385.
• Gust ID, Hampson AW, Lavanchy D, Planning for the next pandemic of influenza, Rev Med Virol. 2001 Jan-Feb;11(1):59-70.
• Gustafsson MG., Extended resolution fluorescence microscopy, Curr Opin Struct Biol. 1999 Oct; 9(5):627-34.
• Guttmacher A., Collins F., Genomic Medicine - A Primer. New England Journal of Medicine, 2002; 19:1512-1520.
• Guttmacher, A., Collins F., Welcome to the genomic era. Editorial: New England Journal of Medicine, 2003, 349:996-998.
• Guzey C, Spigset O., Genotyping as a tool to predict adverse drug reactions, Curr Top Med Chem. 2004;4(13):1411-21.
• Haggarty SJ., The principle of complementarity: chemical versus biological space, Curr Opin Chem Biol. 2005 Jun;9(3):296-303.
• Halapi E, Stefansson K, Hakonarson H., Population genomics of drug response, Am J Pharmacogenomics. 2004;4(2):73-82.
• Hale M, Gillespie WR, Gupta SK, Tuk B, Holford NH., Clinical trial simulation: streamlining your drug development process, Applied Clinical Trials 1996 Aug;5(8):35-40.
• Han M, Gao X, Su JZ, Nie S., Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules, Nat Biotechnol. 2001 Jul; 19(7):631-5.
• Hansch C, Unger SH, Forsythe AB., Strategy in drug design. Cluster analysis as an aid in the selection of substituents, J Med Chem. 1973 Nov;16(11):1217-22.
• Haraguchi T., Live cell imaging: approaches for studying protein dynamics in living cells, Cell Struct Funct. 2002 Oct; 27(5):333-4.
• Haraguchi T, Shimi T, Koujin T, Hashiguchi N, Hiraoka Y., Spectral imaging fluorescence microscopy, Genes Cells. 2002b Sep;7(9):881-7.
• Hardin PE., Transcription regulation within the circadian clock: the E-box and beyond, J Biol Rhythms. 2004 Oct; 19(5):348-60.
• Hardy J, Selkoe DJ., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science. 2002 Jul 19; 297(5580):353-6.
• Harms E, Kivimae S, Young MW, Saez L., Posttranscriptional and posttranslational regulation of clock genes, J Biol Rhythms. 2004 Oct; 19(5):361-73.
• Harrison A, Pearl F, Sillitoe I, Slidel T, Mott R, Thornton J, Orengo C., Recognizing the fold of a protein structure, Bioinformatics. 2003 Sep 22;19(14):1748-59.
• Hartge P., Genes, hormones, and pathways to breast cancer, New Engl J Med. 2003 Jun 5; 348(23):2352-4.
• Hartman JL 4th, Garvik B, Hartwell L., Principles for the buffering of genetic variation, Science. 2001 Feb 9; 291(5506):1001-4.
• Hartman JL 4th, Tippery N.P., Systematic quantification of gene interactions by phenotypic array analysis, Genome Biol. 2004; 5(7): R49.
• Hartwell, L.H., Hopfield, J.J., Leibler, S., and Murray, A.W., From molecular to modular cell biology, Nature 1999; 402: C47�52.
• Hastings MH, Herzog ED., Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei, J Biol Rhythms. 2004 Oct; 19(5):400-13.
• Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsh-Volders M, Oleson FB Jr, Pacchierotti F, Romagna F, Shimada H, et al., In vivo rodent erythrocyte micronucleus assay, Mutat Res. 1994 Jun;312(3):293-304.
• He Q, Li J, Bettiol E, Jaconi ME., Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people, J Gerontol A Biol Sci Med Sci. 2003 Mar; 58(3):279-87.
• Heckl S, Pipkorn R, Nagele T, Vogel U, Kuker W, Voight K., Molecular imaging: Bridging the gap between neuroradiology and neurohistology, Histol Histopathol. 2004 Apr; 19(2):651-68.
• Heit JJ, Kim SK., Embryonic stem cells and islet replacement in diabetes mellitus, Pediatr Diabetes. 2004 Dec; 5 Suppl 2:5-15.
• Hell SW., Toward fluorescence nanoscopy, Nat Biotechnol. 2003 Nov; 21(11):1347-55.
• Hell SW, Dyba M, Jakobs S., Concepts for nanoscale resolution in fluorescence microscopy, Curr Opin Neurobiol. 2004 Oct; 14(5):599-609.
• Hengstler JG, Van der Burg B, Steinberg P, Oesch F., Interspecies differences in cancer susceptibility and toxicity, Drug Metab Rev. 1999 Nov;31(4):917-70.
• Hermann A, Gerlach M, Schwarz J, Storch A., Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration, Expert Opin Biol Ther. 2004 Feb; 4(2):131-43.
• Herz JM, Thomsen WJ, Yarbrough GG., Molecular approaches to receptors as targets for drug discovery, J Recept Signal Transduct Res. 1997 Sep;17(5):671-776.
• Hesse J, Wechselberger C, Sonnleitner M, Schindler H, Schutz GJ., Single-molecule reader for proteomics and genomics, J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Dec 25; 782(1-2):127-35.
• Heymann DL., The international response to the outbreak of SARS in 2003, Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1127-9.
• Hidalgo IJ, Raub TJ, Borchardt RT., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 3:736-49.
• Higgins G, Athey B, Bassingthwaighte J, Burgess J, Champion H, Cleary K, Dev P, Duncan J, Hopmeier M, Jenkins D, Johnson C, Kelly H, Leitch R, Lorensen W, Metaxas D, Spitzer V, Vaidehi N, Vosburgh K, Winslow R., Final report of the meeting "modeling & simulation in medicine: towards an integrated framework". July 20-21, 2000, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA, Comput Aided Surg. 2001;6(1):32-9.
• Hill KP, Ross JS, Egilman DS, Krumholz HM., The ADVANTAGE seeding trial: a review of internal documents, Ann Intern Med. 2008 Aug 19;149(4):251-8.
• Hinshelwood MM, Corbin CJ, Tsang PC, Simpson ER, Isolation and characterization of a complementary deoxyribonucleic acid insert encoding bovine aromatase cytochrome P450, Endocrinology. 1993 Nov; 133(5):1971-7.
• Hoh, J.H., Hansma, P.K., Atomic force microscopy for high-resolution imaging in cell biology, Trends Cell Bio. 1992; 2:208-213.
• Holford NH, Kimko HC, Monteleone JP, Peck CC., Simulation of clinical trials, Annu Rev Pharmacol Toxicol. 2000;40:209-34.
• Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN., Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background, Genes Brain Behav. 2003 Dec; 2(6):365-80.
• Hondeghem LM, Lu HR, van Rossem K, De Clerck F., Detection of proarrhythmia in the female rabbit heart: blinded validation, J Cardiovasc Electrophysiol. 2003 Mar;14(3):287-94.
• Hoogland C., Mostaguir K., Sanchez J.-C., Hochstrasser D.F., Appel R.D, SWISS-2DPAGE, ten years later, Proteomics 2004; 4(8):2352-2356.
• Horn RJ., DICOM additions and advances: the standards committee works to keep up with technology, Healthc Inform. 2004 Sep;21(9):48, 50.
• Horrobin DF, Innovation in the pharmaceutical industry, J R Soc Med, 2000; 93: 341-345
• Horrobin DF, Realism in drug discovery-could Cassandra be right?, Nature biotechnology, 2001, 19, 1099-1100
• Horrobin DF, Modern biomedical research: an internally self-consistent universe with little contact with medical reality?,Nat Rev Drug Discov. 2003 Feb;2(2):151-4.
• Howe JG, Hershey JW, A sensitive immunoblotting method for measuring protein synthesis initiation factor levels in lysates of Escherichia coli, J Biol Chem. 1981 Dec 25;256(24):12836-9.
• Hu, M., Li, Y., Davitt, C.M., Huang, S.M., Thummel, K., Penman, B.W. and Crespi, C.L., Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharmaceutical Research 1999 16: 1352-1359.
• Huang, K., Velliste, M., and Murphy, R.F., Feature reduction for improved recognition of subcellular location pattern in fluorescence microscope images, Manipulation and Analysis of Biomolecules, Cells, and Tissues, Proceedings of SPIE 2003; 4962: 298�306.
• Huang K., Murphy R. F., From Quantitative Microscopy to Automated Image Understanding, J. Biomed. Optics 2004; 9: 893-912
• Huber LA., Is proteomics heading in the wrong direction?, Nat Rev Mol Cell Biol. 2003 Jan;4(1):74-80.
• Hucker HB., Species differences in drug metabolism, Annu Rev Pharmacol. 1970;10:99-118.
• Hull J, Thomson AH, Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis, Thorax. 1998 Dec;53(12):1018-21.
• Hunter, J., Hirst, B.H. and Simmons, N.L., Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharmaceutical Research 1993 10: 743-749.
• Huskey SE, Dean BJ, Bakhtiar R, Sanchez RI, Tattersall FD, Rycroft W, Hargreaves R, Watt AP, Chicchi GG, Keohane C, Hora DF, Chiu SH., Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets, Drug Metab Dispos. 2003 Jun;31(6):785-91.
• Iannuzzi MC, Collins FS, Reverse genetics and cystic fibrosis, Am J Respir Cell Mol Biol. 1990 Apr;2(4):309-16.
• Iborra F, Cook PR, Jackson DA., Applying microscopy to the analysis of nuclear structure and function, Methods. 2003 Feb;29(2):131-41.
• Ideker T., Galitski T.,Hood L.,A new Approach to decoding life: Systems Biology, Annu. Rev. Genomics Hum. Genet., 2001, 2:343�72.
• Ikeda M., Calcium dynamics and circadian rhythms in suprachiasmatic nucleus neurons, Neuroscientist. 2004 Aug; 10(4):315-24.
• Iketaki Y, Watanabe T, Ishiuchi S, Sakai M, Omatsu T, Yamamoto K, Fujii M., Predicted spatial resolution of super-resolving fluorescence microscopy using two-color fluorescence dip spectroscopy, Appl Spectrosc. 2003 Oct;57(10):1312-6.
• Imahara SD, O'Keefe GE, Genetic determinants of the inflammatory response, Curr Opin Crit Care. 2004 Oct;10(5):318-324.
• Isola LM, Gordon JW., Transgenic animals: a new era in developmental biology and medicine, Biotechnology. 1991;16:3-20.
• Jain, A.K., Duin, R.P.W., and Mao, J., Statistical pattern recognition: A review. IEEE Transactions on Pattern Analysis and Machine Intelligence 2000; 22: 4�37.
• Jeong JG, Kim JM, Cho H, Hahn W, Yu SS, Kim S, Effects of IL-1beta on gene expression in human rheumatoid synovial fibroblasts, Biochem Biophys Res Commun. 2004 Nov 5;324(1):3-7.
• Jiang YH, Bressler J, Beaudet AL., Epigenetics and human disease, Annu Rev Genomics Hum Genet. 2004;5:479-510.
• Jones RL, Judson IR., The development and application of imatinib, Expert Opin Drug Saf. 2005 Mar;4(2):183-91.
• Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M., Risk of cardiovascular events and rofecoxib: cumulative meta-analysis, Lancet. 2004 Dec 4;364(9450):2021-9.
• Kalow W., Human pharmacogenomics: the development of a science, Hum Genomics. 2004 Aug; 1(5):375-80.
• Kamb A., What's wrong with our cancer models? , Nat Rev Drug Discov. 2005 Feb; 4(2):161-5.
• Kararli TT., Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm Drug Dispos. 1995 Jul;16(5):351-80.
• Kawasaki ES., Microarrays and the gene expression profile of a single cell, Ann N Y Acad Sci. 2004 May;1020:92-100.
• Kell DB, Oliver SG., Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era, Bioessays. 2004 Jan;26(1):99-105.
• Kelland LR., Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development, Eur J Cancer. 2004 Apr;40(6):827-36.
• Kelloff GJ, Krohn KA, Larson SM, Weissleder R, Mankoff DA, Hoffman JM, Link JM, Guyton KZ, Eckelman WC, Scher HI, O'Shaughnessy J, Cheson BD, Sigman CC, Tatum JL, Mills GQ, Sullivan DC, Woodcock J., The progress and promise of molecular imaging probes in oncologic drug development, Clin Cancer Res. 2005 Nov 15;11(22):7967-85.
• Kelly TL, Trasler JM, Reproductive epigenetics, Clin Genet. 2004 Apr;65(4):247-60.
• Kenakin T., Predicting therapeutic value in the lead optimization phase of drug Discovery, Nat Rev Drug Discov. 2003 Jun; 2(6):429-38.
• Kenakin T., Efficacy at G-protein-coupled receptors, Nat Rev Drug Discov. 2002 Feb; 1(2):103-10.
• Kennedy, T. Managing the drug discovery/development interface. Drug Discovery Today, 2:436-444 (1997).
• Kenworthy, A. K., Edidin, M., Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 Angstrom using imaging fluorescence resonance energy transfer, J. Cell Biol. 1998; 142, 69�84.
• Kerbel RS., Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved, Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S134-9.
• Kermani F, Findlay G, The Pharmaceutical R&D Compendium: CMR International/Scrip's Complete Guide to Trends in R&D (2000)
• Kim SU., Human neural stem cells genetically modified for brain repair in neurological disorders, Neuropathology. 2004 Sep; 24(3):159-71.
• Kimple RJ, Willard FS, Siderovski DP., The GoLoco motif: heralding a new tango between G protein signaling and cell division, Mol Interv. 2002 Apr;2(2):88-100.
• Kind AH, Zakowski LJ, McBride PE., Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction, WMJ. 2002;101(7):53-6.
• Kinzler KW, Vogelstein B., Lessons from hereditary colorectal cancer, Cell. 1996 Oct 18; 87(2):159-70.
• Kirkland SC, Bailey IG., Establishment and characterisation of six human colorectal adenocarcinoma cell lines, Br J Cancer. 1986 Jun;53(6):779-85..
• Kittredge C., A shrinking target, The Scientist 2005, 19(7): 46-48.
• Klapa MI, Quackenbush J., The quest for the mechanisms of life, Biotechnol Bioeng. 2003 Dec 30; 84(7):739-42.
• Klink D, Schindelhauer D, Laner A, Tucker T, Bebok Z, Schwiebert EM, Boyd AC, Scholte BJ, Gene delivery systems--gene therapy vectors for cystic fibrosis, J Cyst Fibros. 2004 Aug;3 Suppl 2:203-12.
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B., Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann Neurol. 2004 Mar;55(3):306-19.
• Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, Debnath ML, Holt DP, Huang GF, Shao L, DeKosky ST, Price JC, Mathis CA, Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain, J Neurosci. 2005 Nov 16;25(46):10598-606.
• Koch WH., Technology platforms for pharmacogenomic diagnostic assays, Nat Rev Drug Discov. 2004 Sep; 3(9):749-61.
• Kola I., Landis J., Can the pharmaceutical industry reduce attrition rates?, Nature Reviews Drug Discovery, 2004, 3, 711 -716.
• Kola I, Hazuda D., Innovation and greater probability of success in drug discovery and development - from target to biomarkers, Curr Opin Biotechnol. 2005 Dec;16(6):644-6. Epub 2005 Nov 2.
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP, Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nat Med. 1998 Jul; 4(7):844-7.
• Koo EH., The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?, Traffic. 2002 Nov;3(11):763-70.
• Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosman A, Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands, Lancet. 2004 Feb 21;363(9409):587-93.
• Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G, Multiple links between transcription and splicing, RNA. 2004 Oct;10(10):1489-98.
• Kost GJ., Theory of network planning for laboratory research and development, Am J Clin Pathol. 1983 Mar;79(3):353-9.
• Kost GJ., Application of Program Evaluation and Review Technic (PERT) to laboratory research and development planning, Am J Clin Pathol. 1986 Aug;86(2):186-92.
• Kostrzewa RM, Segura-Aguilar J., Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review, Neurotox Res. 2003;5(6):375-83.
• Kriete A, Anderson MK, Love B, Freund J, Caffrey JJ, Young MB, Sendera TJ, Magnuson SR, Braughler JM., Combined histomorphometric and gene-expression profiling applied to toxicology, Genome Biol. 2003;4(5):R32. Epub 2003 Apr 30.
• Kristiansen K., Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function., Pharmacol Ther. 2004 Jul; 103(1):21-80.
• Kubinyi H., Drug Research: Myths, Hype and Reality, Nature Rev. Drug Discov. 2 (8), 665-668 (2003).
• Kuhlmann J., Alternative strategies in drug development: clinical pharmacological aspects, Int J Clin Pharmacol Ther. 1999 Dec; 37(12):575-83.
• Kuiken T., Rimmelzwaan G., van Riel D., van Amerongen G., Baars M., Fouchier R., Albert Osterhaus A., Avian H5N1 influenza in cats, Science Express Brevia, 2 Sept.� 2004, Published Online.
• Kukuruzinska MA, Lennon K, Protein N-glycosylation: molecular genetics and functional significance, Crit Rev Oral Biol Med. 1998;9(4):415-48.
• Kumar A, Agarwal S, Heyman JA, Matson S, Heidtman M, Piccirillo S, Umansky L, Drawid A, Jansen R, Liu Y, Cheung KH, Miller P, Gerstein M, Roeder GS, Snyder M, Subcellular localization of the yeast proteome, Genes Dev. 2002 Mar 15;16(6):707-19.
• Kumble KD., Protein microarrays: new tools for pharmaceutical development, Anal Bioanal Chem. 2003 Nov; 377(5):812-9.
• Kunkel EJ, Dea M, Ebens A, Hytopoulos E, Melrose J, Nguyen D, Ota KS, Plavec I, Wang Y, Watson SR, Butcher EC, Berg EL., An integrative biology approach for analysis of drug action in models of human vascular inflammation, FASEB J. 2004 Aug;18(11):1279-81. Epub 2004 Jun 18.
• Kuramoto H., Studies of the growth and cytogenetic properties of human endometrial adenocarcinoma in culture and its development into an established line, Acta Obstet Gynaecol Jpn. 1972 Jan;19(1):47-58.
• Lamond AI, Sleeman JE., Nuclear substructure and dynamics, Curr Biol. 2003 Oct 28;13(21):R825-8.
• Lander ES, et al., Initial sequencing and analysis of the human genome, Nature. 2001 Feb 15;409(6822):860-921.
• Lansbury PT Jr., Back to the future: the 'old-fashioned' way to new medications for Neurodegeneration, Nat Med. 2004 Jul;10 Suppl:S51-7.
• Lappin G, Garner RC., Big physics, small doses: the use of AMS and PET in human microdosing of development drugs, Nat Rev Drug Discov. 2003 Mar;2(3):233-40.
• Larijani B, Allen-Baume V, Morgan CP, Li M, Cockcroft S, EGF regulation of PITP dynamics is blocked by inhibitors of phospholipase C and of the Ras-MAP kinase pathway, Curr Biol. 2003 Jan 8;13(1):78-84.
• Laurincova B., Interleukin-1 family: from genes to human disease, Acta Univ Palacki Olomuc Fac Med. 2000; 143:19-29.
• Lawler C, Suk WA, Pitt BR, Croix CM, Watkins SC., Multimodal optical imaging, Am J Physiol Lung Cell Mol Physiol. 2003 Aug; 285(2):L269-80.
• Lazic SE, Barker RA., The future of cell-based transplantation therapies for neurodegenerative disorders, J Hematother Stem Cell Res. 2003 Dec;12(6):635-42.
• Lee HG, Casadesus G, Zhu X, Joseph JA, Perry G, Smith MA., Perspectives on the amyloid-beta cascade hypothesis, J Alzheimers Dis. 2004 Apr;6(2):137-45.
• Lee HG, Casadesus G, Zhu X, Takeda A, Perry G, Smith MA., Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease, Ann N Y Acad Sci. 2004b Jun;1019:1-4.
• Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, Keller S, Weinryb I, Green M, Duan L, Rogers JA, Millham R, O'brien PJ, Sailstad J, Khan M, Ray C, Wagner JA, Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement, Pharm Res. 2006 Jan 12; [Epub ahead of print].
• Legler UF., Experiences with GLP/GCP from the pharmaceutical industry's viewpoint, Methods Find Exp Clin Pharmacol. 1993 May;15(4):233-6.
• Leif RC, Leif SB, Leif SH., CytometryML, an XML format based on DICOM and FCS for analytical cytology data, Cytometry. 2003 Jul; 54A(1):56-65.
• Lengauer C, Kinzler KW, Vogelstein B., Genetic instabilities in human cancers, Nature. 1998 Dec 17; 396(6712):643-9.
• Lengeler JW., Metabolic networks: a signal-oriented approach to cellular models, Biol Chem. 2000 Sep-Oct; 381(9-10):911-20.
• Lennernas H, Palm K, Fagerholm U, Artursson P., Correlation between paracellular and transcellular drug permeability in the human jejunum and Caco-2 monolayers. Pharm Res (Suppl.) 1994; 10: 263.
• Leray, P. and Gallinari, P. 1999, Feature selection with neural networks, Behaviormetrika 26: 1�27.
• Lerner JM, Zucker RM., Calibration and validation of confocal spectral imaging systems, Cytometry. 2004 Nov; 62A(1):8-34.
• LeVine H 3rd., The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide, J Alzheimers Dis. 2004 Jun;6(3):303-14.
• Lewis L, Siegelman S., The pharmaceutical industry, State Health Care Am. 1993;:42-9.
• Lewis W, Day BJ, Copeland WC, Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective, Nat Rev Drug Discov. 2003 Oct;2(10):812-22.
• Lidington EA, Moyes DL, McCormack AM, Rose ML, A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions, Transpl Immunol. 1999 Dec;7(4):239-46.
• Liebel U, Starkuviene V, Erfle H, Simpson JC, Poustka A, Wiemann S, Pepperkok R., A microscope-based screening platform for large-scale functional protein analysis in intact cells, FEBS Lett. 2003 Nov 20; 554(3):394-8.
• Liebmann C., G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts, Curr Pharm Des. 2004; 10(16):1937-58.
• Liebman MN, Opening Pandora�s Box: Clinical Data and the Study of Complex Diseases, Science's STKE, 2002, 1-4.
• Lin J, Sahakian DC, de Morais SM, Xu JJ, Polzer RJ, Winter SM., The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery, Curr Top Med Chem. 2003;3(10):1125-54.
• Linder CC., The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases, Lab Anim (NY). 2001 May; 30(5):34-9.
• Lindsay MA., Target discovery, Nat Rev Drug Discov. 2003 Oct;2(10):831-8.
• Lindvall O, Kokaia Z, Martinez-Serrano A., Stem cell therapy for human neurodegenerative disorders-how to make it work, Nat Med. 2004 Jul; 10 Suppl:S42-50.
• Lipinski C.A, Lombardo F., Dominy B.W., Feeney P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Delivery Rev., 1997, 23(1-3), 3-25.
• Lippincott-Schwartz J, Snapp E, Kenworthy A., Studying protein dynamics in living cells, Nat Rev Mol Cell Biol. 2001 Jun;2(6):444-56.
• Lippman Z, Martienssen R., The role of RNA interference in heterochromatic silencing, Nature. 2004 Sep 16; 431(7006):364-70.
• Liu W, Icitovic N, Shaffer ML, Chase GA, The impact of population heterogeneity on risk estimation in genetic counseling, BMC Med Genet. 2004 Jun 30; 5(1):18.
• Llopis J, McCaffery JM, Miyawaki A, Farquhar MG, Tsien RY., Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins, Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6803-8.
• Loew C.J., PhD. Vice President, Scientific & Regulatory Affairs Pharmaceutical Research & Manufacturers of America(PhRMA), HHS Public Meeting, November 8, 2004.
• Loew LM, Schaff JC., The Virtual Cell: A software environment for computational cell biology. Trends in Biotechnology 2001, 19:401-406.
• Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN., Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease, Nat Genet. 2003 Feb; 33(2):177-82. Epub 2003 Jan 13.
• Long AD, Langley CH., The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits, Genome Res. 1999 Aug; 9(8):720-31.
• Lugo TG, Pendergast AM, Muller AJ, Witte ON., Tyrosine kinase activity and transformation potency of bcr-abl oncogene products, Science. 1990 Mar 2;247(4946):1079-82..
• Luyten WH, Leysen JE., Receptor cloning and heterologous expression--towards a new tool for drug discovery, Trends Biotechnol. 1993 Jun;11(6):247-54.
• Macaluso M, Giordano A., How does DNA methylation mark the fate of cells?, Tumori. 2004 Jul-Aug; 90(4):367-72.
• Macdonald SJ, Long AD., A potential regulatory polymorphism upstream of hairy is not associated with bristle number variation in wild-caught Drosophila, Genetics. 2004 Aug; 167(4):2127-31.
• Mackay TF., The nature of quantitative genetic variation revisited: lessons from Drosophila bristles, Bioessays. 1996 Feb; 18(2):113-21.
• Maggini M, Raschetti R, Traversa G, Bianchi C, Caffari B, Da Cas R, Panei P., The cerivastatin withdrawal crisis: a "post-mortem" analysis, Health Policy. 2004 Aug;69(2):151-7.
• Mann M, Bartolomei M, Epigenetic reprogramming in the mammalian embryo: struggle of the clones, Genome Biol. 2002; 3(2): reviews1003.1-reviews1003.4.
• Martin GR., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, Proc Natl Acad Sci USA 1981;78:7634�7638.
• McAdams HH, Arkin A., It's a noisy business! Genetic regulation at the nanomolar scale, Trends Genet. 1999 Feb; 15(2):65-9.
• Martin AC, Orengo CA, Hutchinson EG, Jones S, Karmirantzou M, Laskowski� RA, Mitchell JB, Taroni C, Thornton JM, Protein folds and functions, Structure. 1998 Jul 15;6(7):875-84.
• MacGregor JT, Farr S, Tucker JD, Heddle JA, Tice RR, Turteltaub KW., New molecular endpoints and methods for routine toxicity testing, Fundam Appl Toxicol. 1995 Jul;26(2):156-73.
• Maddison K, Clarke AR., New approaches for modelling cancer mechanisms in the mouse, J Pathol. 2005 Jan;205(2):181-93.
• Masure S, Geerts H, Cik M, Hoefnagel E, Van Den Kieboom G, Tuytelaars A, Harris S, Lesage AS, Leysen JE, Van Der Helm L, Verhasselt P, Yon J, Gordon RD, Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants, Eur J Biochem. 1999 Dec;266(3):892-902.
• Mattson MP., Pathways towards and away from Alzheimer's disease, Nature. 2004 Aug 5;430(7000):631-9.
• Maurer W., Creative and innovative statistics in clinical research and development, Methods Inf Med. 2005;44(4):551-60.
• Mauro MJ, Druker BJ., STI571: targeting BCR-ABL as therapy for CML, Oncologist. 2001;6(3):233-8.
• Maxwell SA, Kurzrock R, Parsons SJ, Talpaz M, Gallick GE, Kloetzer WS, Arlinghaus RB, Kouttab NM, Keating MJ, Gutterman JU., Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients, Cancer Res. 1987 Mar 15;47(6):1731-9.
• McBride WG, Thalidomide and congenital abnormalities, Lancet 1961;2:1358.
• McKay JA, Williams EA, Mathers JC, Folate and DNA methylation during in utero development and aging, Biochem Soc Trans. 2004 Dec;32(Pt 6):1006-7.
• McKone EF, Emerson SS, Edwards KL, Aitken ML, Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study, Lancet. 2003 May 17;361(9370):1671-6.
• McMichael AJ, Environmental and social influences on emerging infectious diseases: past, present and future, Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1049-58.
• McNally HA, Borgens RB., Three-dimensional imaging of living and dying neurons with atomic force microscopy, J Neurocytol. 2004 Mar; 33(2):251-8.
• Medvedova L, Farkas R, Hormonal control of protein glycosylation: role of steroids and related lipophilic ligands, Endocr Regul. 2004 Jun; 38(2):65-79.
• Mello CC, Conte D Jr., Revealing the world of RNA interference, Nature. 2004 Sep 16; 431(7006):338-42.
• Michalet, X., Pinaud, F., Lacoste, T. D., Dahan, M., Bruchez, M. P., Alivisatos, A. P., Weiss. S., Properties of Fluorescent Semiconductor Nanocrystals and their Application to Biological Labeling, Single Molecules 2001; 3: 261-276.
• Michalet, X., Weiss. S., Single-molecule spectroscopy and microscopy, Comptes rendus Physique 2002; 2 (4): 619-644.
• Michalet, X., Kapanidis, A.N., Laurence, T., Pinaud, F., Doose, S., Pflughoefft, M., and Weiss, S., The power and prospects of fluorescence microscopies and spectroscopies, Annual Reviews in Biophysics and Biomolecular Structures 2003; 32: 161-182.
• Miklos GL, Maleszka R., Microarray reality checks in the context of a complex disease, Nat Biotechnol. 2004 May;22(5):615-21.
• Miyawaki A, Llopis J, Heim R, McCaffery JM, Adams JA, Ikura M, Tsien RY., Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin, Nature. 1997 Aug 28; 388(6645):882-7.
• Mocellin S, Provenzano M., RNA interference: learning gene knock-down from cell physiology, J Transl Med. 2004; 2(1): 39.
• Morens DM, Folkers GK, Fauci AS., The challenge of emerging and re-emerging infectious diseases, Nature. 2004 Jul 8; 430(6996):242-9.
• Morfis M, Christopoulos A, Sexton PM., RAMPs: 5 years on, where to now? , Trends Pharmacol Sci. 2003 Nov; 24(11):596-601.
• Moynihan R., Court hears how drug giant Merck tried to neutralise and discredit doctors critical of Vioxx, BMJ. 2009 Apr 6;338:b1432.
• Murphy RF, Chused TM., A proposal for a flow cytometric data file standard, Cytometry. 1984 Sep;5(5):553-5.
• Murphy, R.F., Velliste, M., and Porreca, G., Robust classification of subcellular location patterns in fluorescence microscope images. In Proceedings of the 2002 IEEE International Workshop on Neural Networks Signal Processing (NNSP 12) 2002; 67-76.
• Murphy R. F., Automated Determination of Subcellular Location from Confocal Microscope Images, Microsc. Microanal. 2004; 10 (Suppl. 2): 1242-1243.
• Murzin A. G., Brenner S. E., Hubbard T., Chothia C., SCOP: a structural classification of proteins database for the investigation of sequences and structures, J. Mol. Biol. 1995; 247, 536-540.
• Nabholz CE, von Overbeck J., Gene-environment interactions and the complexity of human genetic diseases, J Insur Med. 2004; 36(1):47-53.
• Nadal-Ginard B, Smith CW, Patton JG, Breitbart RE., Alternative splicing is an efficient mechanism for the generation of protein diversity: contractile protein genes as a model system, Adv Enzyme Regul. 1991; 31:261-86.
• Nassar AE, Kamel AM, Clarimont C., Improving the decision-making process in structural modification of drug candidates: reducing toxicity, Drug Discov Today. 2004; Dec 15;9(24):1055-64.
• Nattkemper TW., Automatic segmentation of digital micrographs: a survey, Medinfo. 2004, 2004:847-54.
• Newell DR., How to develop a successful cancer drug - molecules to medicines or targets to treatments?, Eur J Cancer. 2005 Mar; 41(5):676-82.
• Nelson SD., Metabolic activation and drug toxicity, J Med Chem. 1982 Jul;25(7):753-65.
• Neubert D, Heger W, Merker HJ, Sames K, Meister R., Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus. II. Elucidation of the susceptible period and of the variability of embryonic stages, Arch Toxicol. 1988 Jan;61(3):180-91.
• Nicholson JK, Connelly J, Lindon JC, Holmes E., Metabonomics: a platform for studying drug toxicity and gene function, Nat Rev Drug Discov. 2002 Feb;1(2):153-61.
• Noble D., Will genomics revolutionise pharmaceutical R&D? , Trends Biotechnol. 2003 Aug; 21(8):333-7.
• Nogues G, Kadener S, Cramer P, de la Mata M, Fededa JP, Blaustein M, Srebrow A, Kornblihtt AR, Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better, IUBMB Life. 2003 Apr-May; 55(4-5):235-41.
• Nohe A, Petersen NO., Analyzing for co-localization of proteins at a cell membrane, Curr Pharm Biotechnol. 2004 Apr; 5(2):213-20.
• Nuydens R, Nuyens R, Cornelissen F, Geerts H.,The fast axonal transport in hippocampal neurones is acutely enhanced by db-cAMP, Neuroreport. 1993 Feb;4(2):179-82.
• Nurminen M., Statistical significance--a misconstrued notion in medical research, Scand J Work Environ Health. 1997 Jun; 23(3):232-5.
• Nuydens R, De Jong M, Nuyens R, Cornelissen F, Geerts H., Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity, Neurobiol Aging. 1995 May-Jun;16(3):465-75; discussion 475-7.
• Nuydens R, Heers C, Chadarevian A, De Jong M, Nuyens R, Cornelissen F, Geerts H., Sodium butyrate induces aberrant tau phosphorylation and programmed cell death in human neuroblastoma cells, Brain Res. 1995b Aug 7;688(1-2):86-94.
• Nuydens R, de Jong M, Van Den Kieboom G, Heers C, Dispersyn G, Cornelissen F, Nuyens R, Borgers M, Geerts H., Okadaic acid-induced apoptosis in neuronal cells: evidence for an abortive mitotic attempt, J Neurochem. 1998 Mar; 70(3):1124-33.
• Ohashi J, Tokunaga K., The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers, J Hum Genet. 2001; 46(8):478-82.
• Okamura H., Clock genes in cell clocks: roles, actions, and mysteries, J Biol Rhythms. 2004 Oct; 19(5):388-99.
• Olbrich HG, Geerts H, Waldmann U, Mutschler E, Ver Donck L, Kober G, Kaltenbach M., The effect of cyclosporine on electrically paced isolated rat cardiomyocytes, Transplantation, 1991 May;51(5):972-6.
• Olson KR, Olmsted JB., Analysis of microtubule organization and dynamics in living cells using green fluorescent protein-microtubule-associated protein 4 chimeras, Methods Enzymol. 1999; 302:103-20.
• Omta, S.W.F., Critical success factors in biomedical research and pharmaceutical innovation, Kluwer Academic Publishers, 1995.
• Orengo, C.A., Michie, A.D., Jones, S., Jones, D.T., Swindells, M.B., Thornton, J.M., CATH- A Hierarchic Classification of Protein Domain Structures, Structure. 1997; Vol 5. No 8. p.1093-1108.
• Orengo CA, Bray JE, Buchan DW, Harrison A, Lee D, Pearl FM, Sillitoe I, Todd AE, Thornton JM., The CATH protein family database: a resource for structural and functional annotation of genomes, Proteomics. 2002 Jan; 2(1):11-21.
• Ortoleva P, Berry E, Brun Y, Fan J, Fontus M, Hubbard K, Jaqaman K, Jarymowycz L, Navid A, Sayyed-Ahmad A, Shreif Z, Stanley F, Tuncay K, Weitzke E, Wu LC., The Karyote physico-chemical genomic, proteomic, metabolic cell modeling system, OMICS. 2003 Fall;7(3):269-83..
• Pagano M, Jackson PK., Wagging the dogma; tissue-specific cell cycle control in the mouse embryo, Cell. 2004 Sep 3; 118(5):535-8.
• Palmblad M, Buchholz BA, Hillegonds DJ, Vogel JS., Neuroscience and accelerator mass spectrometry, J Mass Spectrom. 2005 Feb;40(2):154-9.
• Parekh RB, Rohlff C., Post-translational modification of proteins and the discovery of new medicine, Curr Opin Biotechnol. 1997 Dec; 8(6):718-23.
• Paris S, Sesboue R., Metastasis models: the green fluorescent revolution?, Carcinogenesis. 2004 Dec; 25(12):2285-92. Epub 2004 Jun 24.
• Parrott N, Paquereau N, Coassolo P, Lave T., An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery, J Pharm Sci. 2005 Oct;94(10):2327-43.
• Paul J, Seib R, Prescott T., The Internet and clinical trials: background, online resources, examples and issues, J Med Internet Res. 2005 Mar 16;7(1):e5.
• Pearson H., Surviving a knockout blow, Nature. 2002 Jan 3; 415(6867):8-9.
• Pearl F, Todd A, Sillitoe I, Dibley M, Redfern O, Lewis T, Bennett C, Marsden R, Grant A, Lee D, Akpor A, Maibaum M, Harrison A, Dallman T, Reeves G, Diboun I, Addou S, Lise S, Johnston C, Sillero A, Thornton J, Orengo C., The CATH Domain Structure Database and related resources Gene3D and DHS provide comprehensive domain family information for genome analysis, Nucleic Acids Res. 2005 Jan 1;33 Database Issue:D247-51.
• Peiris, J.S.M. et al, Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361
• Peltekova VD, et al., Functional variants of OCTN cation transporter genes are associated with Crohn disease, Nat Genet. 2004 May; 36(5):471-5. Epub 2004 Apr 11.
• Pendergast AM, Witte ON., Role of the ABL oncogene tyrosine kinase activity in human leukaemia, Baillieres Clin Haematol. 1987 Dec;1(4):1001-20.
• Pennisi E., Gene Counters Struggle to Get the Right Answer, Science 2003; 301: 1040�1041.
• Perfetto SP, Chattopadhyay PK, Roederer M, Seventeen-colour flow cytometry: unravelling the immune system, Nat Rev Immunol. 2004 Aug;4(8):648-55.
• Perkins DO, Jeffries C, Sullivan P, Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia, Mol Psychiatry. 2004 Sep 21.
• Perlin MW, Szabady B., Hum Mutat. 2002 Apr;19(4):361-73., Determining sequence length or content in zero, one, and two dimensions.
• Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ., Multidimensional drug profiling by automated microscopy, Science. 2004 Nov 12; 306(5699):1194-8.
• Peti-Peterdi J, Bell PD., Confocal and two-photon microscopy, Methods Mol Med. 2003;86:129-38.
• Peterson JK, Houghton PJ., Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development, Eur J Cancer. 2004 Apr;40(6):837-44.
• Pham NA, Richardson T, Cameron J, Chue B, Robinson BH., Altered mitochondrial structure and motion dynamics in living cells with energy metabolism defects revealed by real time microscope imaging, Microsc Microanal. 2004 Apr; 10(2):247-60.
• Pimpl P, Denecke J., Protein-protein interactions in the secretory pathway, a growing demand for experimental approaches in vivo, Plant Mol Biol. 2002 Dec;50(6):887-902.
• Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM., Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ. 2004 Jul 3;329(7456):15-9 .
• Piston DW, Knobel SM., Real-time Analysis of Glucose Metabolism by Microscopy, Trends Endocrinol Metab. 1999 Dec; 10(10):413-417.
• Piston DW., Imaging living cells and tissues by two-photon excitation microscopy, Trends Cell Biol. 1999 Feb;9(2):66-9.
• Politz, J., van Driel, R., Sauer, M. & Pombo, A., From linear genome sequence to three-dimensional organization of the cell nucleus, Genome Biology 2003, 4, 310-311.
• Poly WJ., Nongenetic variation, genetic-environmental interactions and altered gene expression. III. Posttranslational modifications, Comp Biochem Physiol A Physiol. 1997 Nov; 118(3):551-72.
• Pombo, A., Cellular genomics: which genes are transcribed when and where?, Trends in Biochemical Science 2003, 28, 6-9.
• Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, Ivanova A, Ageyeva L, Tourkova V, Balatoni J, Bornmann W, Blasberg R, Gelovani Tjuvajev J., A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging, Eur J Nucl Med Mol Imaging. 2004 May;31(5):740-51. Epub 2004 Mar 11.
• Ponten J, Saksela E, Two established in vitro cell lines from human mesenchymal tumours, Int J Cancer. 1967 Sep 15; 2(5):434-47.
• Pray L., Refining Transgenic Mice, The Scientist 2002; 16(13): 34. .
• Prentis RA, Lis Y, Walker SR., Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985), Br J Clin Pharmacol. 1988 Mar;25(3):387-96.
• Price J. H., Goodacre A., Hahn K., Hodgson L., Hunter E. A., Krajewski S., Murphy R. F., Rabinovich A., Reed J. C., and Heynen S., Advances in Molecular Labeling, High Throughput Imaging and Machine Intelligence Portend Powerful Functional Cellular Biochemistry Tools,� J. Cell. Biochem., 2003, Supp. 39: 194-210
• Pritchard JF, Jurima-Romet M, Reimer ML, Mortimer E, Rolfe B, Cayen MN, Making better drugs: Decision gates in non-clinical drug development, Nat Rev Drug Discov. 2003 Jul;2(7):542-53.
• Projan SJ., Why is big Pharma getting out of antibacterial drug discovery?, Curr Opin Microbiol. 2003 Oct;6(5):427-30.
• Raff M., Adult stem cell plasticity: fact or artifact?, Annu Rev Cell Dev Biol. 2003; 19:1-22.
• Ranga S, Trivedi N, Khurana SK, Thergaonkar A, Talib VH, Emerging and re-emerging infections, Indian J Pathol Microbiol. 1997 Oct;40(4):569-81.
• Raser JM, O'Shea EK., Control of stochasticity in eukaryotic gene expression, Science. 2004 Jun 18;304(5678):1811-4. Epub 2004 May 27.
• Raskin S, Pereira L, Reis F, Rosario NA, Ludwig N, Valentim L, Phillips JA 3rd, Allito B, Heim RA, Sugarman EA, Probst C, Faucz F, Culpi L, High allelic heterogeneity between Afro-Brazilians and Euro-Brazilians impacts cystic fibrosis genetic testing, Genet Test. 2003 Fall;7(3):213-8.
• Ratti E, Trist D., The continuing evolution of the drug discovery process in the pharmaceutical industry, Farmaco. 2001 Jan-Feb;56(1-2):13-9..
• Ravnan SL, Locke C, Yee WP, Haase K., Cerivastatin-induced rhabdomyolysis: 11 case reports, Pharmacotherapy. 2002 Apr; 22(4):533-7.
• Rawlins MD., Cutting the cost of drug development?, Nat Rev Drug Discov. 2004 Apr;3(4):360-4.
• Regland B, Gottfries CG., The role of amyloid beta-protein in Alzheimer's disease, Lancet. 1992 Aug 22; 340(8817):467-9.
• Rehfeld JF., Posttranslational attenuation of peptide gene expression, FEBS Lett. 1990 Jul 30; 268(1):1-4.
• Rehfeld JF, Goetze JP., The posttranslational phase of gene expression: new possibilities in molecular diagnosis, Curr Mol Med. 2003 Feb; 3(1):25-38.
• Reik W, Dean W, Walter J, Epigenetic reprogramming in mammalian development, Science. 2001 Aug 10; 293(5532):1089-93.
• Rich DP, Gregory RJ, Cheng SH, Smith AE, Welsh MJ, Effect of deletion mutations on the function of CFTR chloride channels, Receptors Channels. 1993;1(3):221-32.
• Rioux JD, Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease, Nat Genet. 2001 Oct; 29(2):223-8.
• Rives A.W, Galitski T., Modular organization of cellular networks, PNAS, 2003, 100:3; 1128�1133.
• Robb GB, Brown KM, Khurana J, Rana TM., Specific and potent RNAi in the nucleus of human cells, Nat Struct Mol Biol. 2005 Jan 09; [Epub ahead of print]
• Rodriguez MS, Dargemont C, Stutz F., Nuclear export of RNA, Biol Cell. 2004 Oct; 96(8):639-55.
• Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B., Analysis of single-locus tests to detect gene/disease associations, Genet Epidemiol. 2005 Jan 6; [Epub ahead of print]
• Roeder RG., Transcriptional regulation and the role of diverse coactivators in animal cells, FEBS Lett. 2005 Feb 7; 579(4):909-15.
• Roederer M, Brenchley JM, Betts MR, De Rosa SC, Flow cytometric analysis of vaccine responses: how many colors are enough?, Clin Immunol. 2004 Mar; 110(3):199-205.
• Roitberg B, Urbaniak K, Emborg M., Cell transplantation for Parkinson's disease, Neurol Res. 2004 Jun;26(4):355-62.
• Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, et al, Identification of the cystic fibrosis gene: chromosome walking and jumping, Science. 1989 Sep 8; 245(4922):1059-65.
• Rosner B., Fundamentals of Biostatistics, Fourth edition, 1995. ISBN 0-531-20840-8.
• Ross JS, Hill KP, Egilman DS, Krumholz HM., Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation, JAMA. 2008 Apr 16;299(15):1800-12.
• Roux P, Munter S, Frischknecht F, Herbomel P, Shorte SL., Focusing light on infection in four dimensions, Cell Microbiol. 2004 Apr; 6(4):333-43.
• Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA., BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis, PLoS Biol. 2004 Nov; 2(11):e377. Epub 2004 Nov 02.
• Rudmann DG, Durham SK., Utilization of genetically altered animals in the pharmaceutical industry, Toxicol Pathol. 1999 Jan-Feb; 27(1):111-4.
• Russo E., Merging IT and biology, Scientist 2000, 14(23): 8 Nov. 27.
• Rustom A, Gerlich D, Rudolf R, Heinemann C, Eils R, Gerdes HH., Analysis of fast dynamic processes in living cells: high-resolution and high-speed dual-color imaging combined with automated image analysis, Biotechniques. 2000 Apr;28(4):722-8, 730.
• Rutherford SL., From genotype to phenotype: buffering mechanisms and the storage of genetic information, Bioessays. 2000 Dec; 22(12):1095-105.
• Sachse C, Krausz E, Kronke A, Hannus M, Walsh A, Grabner A, Ovcharenko D, Dorris D, Trudel C, Sonnichsen B, Echeverri CJ., High-Throughput RNA Interference Strategies for Target Discovery and Validation by Using Synthetic Short Interfering RNAs: Functional Genomics Investigations of Biological Pathways, Methods Enzymol. 2005; 392:242-77.
• Saijo N., What are the reasons for negative phase III trials of molecular-target-based drugs?, Cancer Sci. 2004 Oct;95(10):772-6.
• Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R., Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies, Drug Saf. 2005;28(8):677-94.
• Salvatore F, Scudiero O, Castaldo G, Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes, Am J Med Genet. 2002 Jul 22;111(1):88-95.
• Samei E, Rowberg A, Avraham E, Cornelius C., Toward Clinically Relevant Standardization of Image Quality, J Digit Imaging. 2004 Nov 25.
• Sandblad B, Meinzer HP., Modelling and simulation of complex control structures in cell biology, Methods Inf Med. 1992 Feb; 31(1):36-43.
• Sanford LP, Kallapur S, Ormsby I, Doetschman T., Influence of genetic background on knockout mouse phenotypes, Methods Mol Biol. 2001; 158:217-25.
• Sangiuolo F, D'Apice MR, Gambardella S, Di Daniele N, Novelli G, Toward the pharmacogenomics of cystic fibrosis - an update, Pharmacogenomics, 2004 Oct;5(7):861-78.
• Sauer B., Inducible gene targeting in mice using the Cre/lox system, Methods. 1998 Apr;14(4):381-92.
• Sauer U., High-throughput phenomics: experimental methods for mapping fluxomes, Curr Opin Biotechnol. 2004 Feb; 15(1):58-63.
mso-list:l1 level1 lfo3;tab-stops:list 36.0pt'>Shaffer C., Drug discovery veers off target, Drug Discov Today. 2005 Nov 15;10(22):1489.
• Sheiner LB., Learning versus confirming in clinical drug development, Clin Pharmacol Ther. 1997 Mar;61(3):275-91.
• Schena M, Shalon D, Davis RW, Brown PO., Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science. 1995 Oct 20;270(5235):467-70.
• Scherr M, Morgan MA, Eder M., Gene silencing mediated by small interfering RNAs in mammalian cells, Curr Med Chem. 2003 Feb; 10(3):245-56.
• Shimomura O, Johnson FH, Saiga Y., Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea, J Cell Comp Physiol. 1962 Jun; 59:223-39.
• Schneider M., A rational approach to maximize success rate in target discovery, Arch Pharm (Weinheim). 2004 Dec; 337(12):625-33.
• Schooley K, Zhu P, Dower SK, Qwarnstrom EE, Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level, Biochem J. 2003 Jan 15;369(Pt 2):331-9.
• Schramm A, Apostolov O, Sitek B, Pfeiffer K, Stuhler K, Meyer HE, Havers W, Eggert A, Proteomics: techniques and applications in cancer research, Klin Padiatr. 2003 Nov-Dec; 215(6):293-7.
• Schuh JC., Trials, tribulations, and trends in tumor modeling in mice, Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:53-66.
• Schulhof J, Schub T., Background noise, Lab Anim (NY). 2001 May; 30(5):9.
• Schwartz WJ, Meijer JH., Real-time imaging reveals spatiotemporal dynamics of cellular circadian clocks, Trends Neurosci. 2004 Sep; 27(9):513-6.
• Seamer LC, Bagwell CB, Barden L, Redelman D, Salzman GC, Wood JC, Murphy RF., Proposed new data file standard for flow cytometry, version FCS 3.0, Cytometry. 1997 Jun 1; 28(2):118-22.
• Seddon AM, Curnow P, Booth PJ, Membrane proteins, lipids and detergents: not just a soap opera, Biochim Biophys Acta. 2004 Nov 3; 1666(1-2):105-17.
• Segal, E., Shapira, M., Regev, A., Pe�er, D., Botstein, D., Koller, D., Friedman, Module networks: Identifying regulatory modules and their condition-specific regulators from gene expression data, Nat. Genet. 2003; 34: 166�176.
• Seinstra F.J.,� Koelma D., Geusebroek J.M., A software architecture for user transparent parallel image processing. Parallel Comput. 2002; 28(7-8):967-993.
• Selinger DW, Wright MA, Church GM., On the complete determination of biological systems, Trends Biotechnol. 2003 Jun;21(6):251-4.
• Selkoe DJ., Alzheimer's disease: genes, proteins, and therapy, Physiol Rev. 2001 Apr;81(2):741-66.
• Seo J, Lee KJ, Post-translational modifications and their biological functions: proteomic analysis and systematic approaches, J Biochem Mol Biol. 2004 Jan 31; 37(1):35-44.
• Sexton PM, Albiston A, Morfis M, Tilakaratne N., Receptor activity modifying proteins, Cell Signal. 2001 Feb; 13(2):73-83.
• Sharp PA., RNA splicing and genes, JAMA. 1988 Nov 25; 260(20):3035-41.
• Shlaes DM., The abandonment of antibacterials: why and wherefore? , Curr Opin Pharmacol. 2003 Oct; 3(5):470-3.
• Shu Y, Hong-Hui L., Transcription, translation, degradation, and circadian clock, Biochem Biophys Res Commun. 2004 Aug 13; 321(1):1-6.
• Sigmund CD., Viewpoint: are studies in genetically altered mice out of control?, Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1425-9.
• Silver RB., Ratio imaging: practical considerations for measuring intracellular calcium and pH in living tissue, Methods Cell Biol. 1998;56:237-51.
• Silver RB, Ratio imaging: measuring intracellular Ca⁺⁺ and pH in living cells, Methods Cell Biol. 2003;72:369-87.
• Simon R, Sauter G., Tissue microarrays for miniaturized high-throughput molecular profiling of tumors, Exp Hematol. 2002 Dec; 30(12):1365-72.
• Slaughter RL, Edwards DJ., Recent advances: the cytochrome P450 enzymes, Ann Pharmacother 1995 29:619-24.
• Sleeman JE., Dynamics of the mammalian nucleus: can microscopic movements help us to understand our genes?, Philos Transact Ser A Math Phys Eng Sci. 2004 Dec 15;362(1825):2775-93.
• Slepchenko BM, Schaff JC, Macara IG, Loew LM., Quantitative Cell Biology with the Virtual Cell. Trends in Cell Biology 2003, 13(11):570-576.
• Smith CC., Comments on comparative patterns of drug metabolism, Fed Proc. 1967 Jul-Aug;26(4):1044-6.
• Smith RL., The problem of species variations, Ann Nutr Aliment. 1974;28(4):335-49.
• Smithies O, Koralewski MA, Song KY, Kucherlapati RS, Homologous recombination with DNA introduced into mammalian cells, Cold Spring Harb Symp Quant Biol. 1984;49:161-70.
• Smithies O., Animal models of human genetic diseases, Trends Genet. 1993 Apr;9(4):112-6..
• Smithies O., Many little things: one geneticist's view of complex diseases, Nat Rev Genet. 2005 May;6(5):419-25..
• Spector DL., The dynamics of chromosome organization and gene regulation, Annu Rev Biochem. 2003; 72:573-608.
• Spielmann H, Liebsch M., Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice, Toxicol In Vitro. 2001 Aug-Oct;15(4-5):585-90.
• Spring DR., Chemical genetics to chemical genomics: small molecules offer big insights, Chem Soc Rev. 2005 Jun;34(6):472-82..
• Stearns T., Green fluorescent protein. The green revolution, Curr Biol. 1995 Mar 1; 5(3):262-4.
• Stelling J, Sauer U, Szallasi Z, Doyle FJ 3rd, Doyle J., Robustness of cellular functions, Cell. 2004 Sep 17; 118(6):675-85.
• Sontag MK, Accurso FJ, Gene modifiers in pediatrics: application to cystic fibrosis, Adv Pediatr. 2004; 51:5-36.
• Souder E, Beck C., Overview of Alzheimer's disease, Nurs Clin North Am. 2004 Sep; 39(3):545-59.
• Staffa JA, Chang J, Green L., Cerivastatin and reports of fatal rhabdomyolysis, N Engl J Med. 2002 Feb 14; 346(7):539-40.
• Stephens DJ, Allan VJ., Light microscopy techniques for live cell imaging, Science. 2003 Apr 4; 300(5616):82-6.
• Stoughton RB, Friend SH., Innovation: How molecular profiling could revolutionize drug discovery, Nat Rev Drug Discov. 2005 Apr; 4(4):345-50.
• Stumm G, Russ A, Nehls M., Deductive genomics: a functional approach to identify innovative drug targets in the post-genome era, Am J Pharmacogenomics. 2002; 2(4):263-71.
• Suggitt M, Bibby MC, 50 years of preclinical anticancer drug screening: empirical to target-driven approaches, Clin Cancer Res. 2005 Feb 1;11(3):971-81.
• Summers KM., Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases, Hum Mutat. 1996; 7(4):283-93.
• Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type, Biochim Biophys Acta. 1999 Dec 10;1489(1):141-58.
• Swedlow JR, Goldberg I, Brauner E, Sorger PK., Informatics and quantitative analysis in biological imaging, Science. 2003 Apr 4; 300(5616):100-2.
• Takahashi JS., Finding new clock components: past and future, J Biol Rhythms. 2004 Oct; 19(5):339-47.
• Takahashi, K., Ishikawa, N., Sadamoto, Y., et al, E-CELL2: Multi-platform E-CELL Simulation System, Bioinformatics, 2003; 19(13):1727-1729.
• Tambyah PA., SARS: responding to an unknown virus, Eur J Clin Microbiol Infect Dis. 2004 Aug; 23(8):589-95. Epub 2004 Jul 14.
• Taylor DL, Woo ES, Giuliano KA, Real-time molecular and cellular analysis: the new frontier of drug discovery, Curr Opin Biotechnol. 2001 Feb; 12(1):75-81.
• Templeton AR., The complexity of the genotype-phenotype relationship and the limitations of using genetic "markers" at the individual level, Sci Context. 1998 Autumn-Winter; 11(3-4):373-89.
• Thornhill MH, Li J, Haskard DO, Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926, Scand J Immunol. 1993 Sep; 38(3):279-86.
• Templeton AR., The complexity of the genotype-phenotype relationship and the limitations of using genetic "markers" at the individual level, Sci Context. 1998 Autumn-Winter; 11(3-4):373-89.
• Thyagarajan T, Totey S, Danton MJ, Kulkarni AB., Genetically altered mouse models: the good, the bad, and the ugly, Crit Rev Oral Biol Med. 2003;14(3):154-74.
• Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM., Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment, J Pharmacol Exp Ther. 2000 Jul; 294(1):61-72.
• Tjio J. H., Puck T. T., Genetics of somatic mammalian cells. II. chromosomal constitution of cells intissue culture. J. Exp. Med. 1958; 108: 259-271.
• Tjio JH, Carbone PP, Whang J, Frei E 3rd., The Philadelphia chromosome and chronic myelogenous leukemia, J Natl Cancer Inst. 1966 Apr;36(4):567-84
• Toulme JJ, Di Primo C, Boucard D., Regulating eukaryotic gene expression with aptamers, FEBS Lett. 2004 Jun 1;567(1):55-62..
• Truong K, Ikura M., The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo, Curr Opin Struct Biol. 2001 Oct; 11(5):573-8.
• Tsien R.Y., A non-disruptive technique for loading calcium buffers and indicators into cells, Nature, 1981, Apr 9; 290(5806):527-8.
• Tsien RY, Harootunian AT, Practical design criteria for a dynamic ratio imaging system, Cell Calcium, 1990, Feb-Mar; 11(2-3):93-109.
• Tsien RY, Miyawaki A., Seeing the machinery of live cells, Science. 1998 Jun 19; 280(5371):1954-5.
• Tsien R.Y., Imagining imaging's future, Nature Reviews Molecular Cell Biology, 2003.
• Turner SM, Hellerstein MK., Emerging applications of kinetic biomarkers in preclinical and clinical drug development, Curr Opin Drug Discov Devel. 2005 Jan;8(1):115-26.
• Turteltaub KW, Felton JS, Gledhill BL, Vogel JS, Southon JR, Caffee MW, Finkel RC, Nelson DE, Proctor ID, Davis JC., Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA, Proc Natl Acad Sci U S A. 1990 Jul;87(14):5288-92.
• Udawela M, Hay DL, Sexton PM., The receptor activity modifying protein family of G protein coupled receptor accessory proteins, Semin Cell Dev Biol. 2004 Jun; 15(3):299-308.
• Uddin M, Wildman DE, Liu G, Xu W, Johnson RM, Hof PR, Kapatos G, Grossman LI, Goodman M., Sister grouping of chimpanzees and humans as revealed by genome-wide phylogenetic analysis of brain gene expression profiles, Proc Natl Acad Sci U S A. 2004 Mar 2; 101(9):2957-62. Epub 2004 Feb 19.
• Urnov FD, Methylation and the genome: the power of a small amendment, J Nutr. 2002 Aug; 132(8 Suppl):2450S-2456S.
• Uversky VN, Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go?, Cell Mol Life Sci. 2003 Sep;60(9):1852-71.
• van Dellen A, Hannan AJ, Genetic and environmental factors in the pathogenesis of Huntington's disease, Neurogenetics. 2004 Feb; 5(1):9-17. Epub 2004 Jan 24.
• Valet G, T�rnok A, Cytomics in predictive medicine, Cytometry, 2003, 53B: 1-3.
• Valet G, T�rnok A, Cytomics - New Technologies: Towards a Human Cytome Project, Cytometry, 2004, 59A: 167-171.
• Valet G, Tarnok A, Potential and challenges of a human cytome project, J Biol Regul Homeost Agents, 2004b, Apr-Jun;18(2): 87-91.
• Valet G, Predictive medicine by cytomics and the challenges of a human cytome project, Business Briefing: Future Drug Discovery 2004, Ed: E Cooper, World Markets Research Center Ltd, London, 2004c; 46-51.
• Valet GK, Hoeffkes HG., Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics, Cytometry A. 2004d Jun; 59(2): 232-6.
• Valet G., Cytomics: an entry to biomedical cell systems biology, Cytometry A. 2005a Feb; 63(2):67-8.
• Valet G., Human cytome project, cytomics, and systems biology: the incentive for new horizons in cytometry, Cytometry A. 2005b Mar; 64A(1):1-2.
• Van Deun K, Van Cauteren H, Vandenberghe J, Canning M, Vanparys P, Coussement W., Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals, Adverse Drug React Toxicol Rev. 1997 Nov;16(4):215-33.
• van Drie JH., Pharmacophore discovery--lessons learned, Curr Pharm Des. 2003;9(20):1649-64.
• Van Osta P., Application of linear scale space and the spatial color model in light microscopy, Spring Meeting NVPHBV, Amsterdam, 12 April 2000.
• Van Osta P., Geusebroek J.M. , Ver Donck K., Bols L., Geysen J., ter Haar Romeny B. M., The principles of scale space applied to structure and colour in light microscopy, Proceedings of the Royal Microscopical Society, Sept. 2002, 37(3), 161-166.
• Van Osta P., Automated Tiled Multi-mode Image Acquisition and Processing Applied to Pharmaceutical Research, 13th ProRISC workshop on Circuits, Systems and Signal Processing, Veldhoven, the Netherlands, 28-29 November 2002b.
• Van Osta P, A Human Cytome Project ?,� Dec. 1 2003, http://news-reader.org/article.php?group=bionet.cellbiol&post_nr=14902
• Van Osta P., Bart Vanherck B., Kris Ver Donck K., Luc Bols L., Geysen J., The M⁵ framework for exploring the cytome, Plenary Session and Discussion: Human Cytome Project, Abstract p. 66, Focus On Microscopy (F.O.M.) 2004, Philadelphia, PA, USA, 4-7 April, 2004.
• Van Herck K, Van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL, Gisler S, Steffen R, Gargalianos P, Lopez-Velez R, Overbosch D, Caumes E, Walker E, Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey, J Travel Med. 2004 Jan-Feb;11(1):3-8.
• Varma, R., Mayor, S., GPI-anchored proteins are organized in submicron domains at the cell surface, Nature 1998; 394, 798�801.
• Vercelli D, Genetics, epigenetics, and the environment: switching, buffering, releasing, J Allergy Clin Immunol. 2004 Mar; 113(3):381-6; quiz 387.
• Ver Donck L, Pauwels PJ, Vandeplassche G, Borgers M., Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers, Life Sci. 1986 Mar 3; 38(9):765-72.
• Ver Donck L, Liu GS, Vandeplassche G, Borgers M., Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes, Basic Res Cardiol. 1987 Jan-Feb; 82(1):74-81.
• Ver Donck L, Van Reempts J, Vandeplassche G, Borgers M., A new method to study activated oxygen species induced damage in cardiomyocytes and protection by Ca²⁺-antagonists, J Mol Cell Cardiol. 1988 Sep; 20(9):811-23.
• Ver Donck L, Verellen G, Vandewiele R, De Clerck F, Borgers M., Class IV Ca²⁺ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes, Cell Biol Int Rep. 1990 Apr; 14(4):399-406.
• Ver Donck L, Borgers M., Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology, Am J Physiol. 1991 Dec; 261(6 Pt 2): H1828-35.
• Ver Donck L, Verellen G, Geerts H, Borgers M., Lysophosphatidylcholine-induced Ca(²⁺)-overload in isolated cardiomyocytes and effect of cytoprotective drugs, J Mol Cell Cardiol. 1992 Sep; 24(9):977-88.
• Venter JC, et al., The sequence of the human genome, Science. 2001 Feb 16; 291(5507):1304-51.
• Vermeer JE, Van Munster EB, Vischer NO, Gadella TW Jr, Probing plasma membrane microdomains in cowpea protoplasts using lipidated GFP-fusion proteins and multimode FRET microscopy, J Microsc. 2004 May; 214(Pt 2):190-200.
• Viallet PM, Vo-Dinh T., Monitoring intracellular proteins using fluorescence techniques: from protein synthesis and localization to activity, Curr Protein Pept Sci. 2003 Oct; 4(5):375-88.
• Voskoglou-Nomikos T, Pater JL, Seymour L., Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models, Clin Cancer Res. 2003 Sep 15;9(11):4227-39.
• Voskova D, Valekova L, Fedorova J, Hudecek J, Kubisz P., Leukemic cells and aberrant phenotypes in acute leukemia patients: a flow cytometry analysis, Neoplasma. 2003; 50(6):422-7.
• Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N., Assessing the probability that a positive report is false: an approach for molecular epidemiology studies, J Natl Cancer Inst. 2004 Mar 17; 96(6):434-42.
• Walter E, Kissel T., Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?, Pharm Res. 1994 Nov;11(11):1575-80.
• Walter J, Paulsen M., Imprinting and disease, Semin Cell Dev Biol. 2003 Feb; 14(1):101-10.
• Wang SJ, Chen JJ., Sample size for identifying differentially expressed genes in microarray experiments, J Comput Biol. 2004; 11(4):714-26.
• Wassenegger M, Heimes S, Riedel L, Sanger HL., RNA-directed de novo methylation of genomic sequences in plants, Cell. 1994 Feb 11; 76(3):567-76.
• Waterman-Storer CM, Danuser G., New directions for fluorescent speckle microscopy, Curr Biol. 2002 Sep 17; 12(18):R633-40.
• Watson A, Wu X, Bruchez M., Lighting up cells with quantum dots, Biotechniques. 2003 Feb;34(2):296-300, 302-3.
• Weatherall DJ., Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias, Nat Rev Genet. 2001 Apr; 2(4):245-55.
• Wei, X. et al, Viral dynamics in HIV-1 infection, Nature1995,� 373: 117-122.
• Weinstein LS., The role of tissue-specific imprinting as a source of phenotypic heterogeneity in human disease, Biol Psychiatry. 2001 Dec 15;50(12):927-31.
• Weitzke EL, Ortoleva PJ., Simulating cellular dynamics through a coupled transcription, translation, metabolic model, Comput Biol Chem. 2003 Oct;27(4-5):469-80.
• Welsh MJ, Smith AE., Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis, Cell. 1993 Jul 2;73(7):1251-4.
• White IN, Brown K., Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology, Trends Pharmacol Sci. 2004 Aug;25(8):442-7.
• White JG, Squirrell JM, Eliceiri KW., Applying multiphoton imaging to the study of membrane dynamics in living cells, Traffic. 2001 Nov; 2(11):775-80.
• Wilding IR, Bell JA., Improved early clinical development through human microdosing studies, Drug Discov Today. 2005 Jul 1;10(13):890-4..
• Wilkinson JJ, Force RW, Cady PS., Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone, Pharmacotherapy. 2004 Aug; 24(8):978-86.
• Williams M., Target validation, Curr Opin Pharmacol. 2003 Oct;3(5):571-7.
• Williams RM, Piston DW, Webb WW., Two-photon molecular excitation provides intrinsic 3-dimensional resolution for laser-based microscopy and icrophotochemistry, FASEB J. 1994 Aug;8(11):804-13.
• Wilson KE, Ryan MM, Prime JE, Pashby DP, Orange PR, O'Beirne G, Whateley JG, Bahn S, Morris CM, Functional genomics and proteomics: application in neurosciences, J Neurol Neurosurg Psychiatry. 2004 Apr; 75(4):529-38.
• Winkle S., Geisseln der Menschheit, Artemis and Winkler, 2^nd edition, 1997, ISBN 3 538 07049 0.
• Wold LE, Dai W, Sesti C, Hale SL, Dow JS, Martin BJ, Kloner RA., Stem cell therapy for the heart, Congest Heart Fail. 2004 Nov-Dec; 10(6):293-301.
• Workman P., New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges, Curr Cancer Drug Targets. 2001 May;1(1):33-47.
• Wright F. A., et al., A Draft Annotation and Overview of the Human Genome, Genome Biology 2001; 2: 1�18.
• Wurflinger T, Stockhausen J, Meyer-Ebrecht D, Bocking A., Robust automatic coregistration, segmentation, and classification of cell nuclei in multimodal cytopathological microscopic images, Comput Med Imaging Graph. 2004 Jan-Mar; 28(1-2):87-98.
• Yagita K, Tamanini F, van Der Horst GT, Okamura H., Molecular mechanisms of the biological clock in cultured fibroblasts, Science. 2001 Apr 13; 292(5515):278-81.
• Yan Z, Caldwell GW., Metabolism profiling, and cytochrome P450 inhibition and induction in drug discovery, Curr Top Med Chem. 2001 Nov; 1(5):403-25.
• Yang Y, Blomme EA, Waring JF., Toxicogenomics in drug discovery: from preclinical studies to clinical trials, Chem Biol Interact. 2004 Nov 1; 150(1):71-85.
• Yeo G, Holste D, Kreiman G, Burge CB, Variation in alternative splicing across human tissues, Genome Biol. 2004;5(10):R74. Epub 2004 Sep 13.
• Young IT., Sampling density and quantitative microscopy, Anal Quant Cytol Histol. 1988 Aug; 10(4):269-75.
• Young MB, DiSilvestro MR, Sendera TJ, Freund J, Kriete A, Magnuson SR, Analysis of gene expression in carbon tetrachloride-treated rat livers using a novel bioarray technology, Pharmacogenomics J., 2003; 3:41-52.
• Zaal, K. J. M. et al., Golgi membranes are absorbed into and reemerge from the ER during mitosis, Cell 1999; 99, 589�601.
• Zhang H, Huang HM, Carson RC, Mahmood J, Thomas HM, Gibson GE., Assessment of membrane potentials of mitochondrial populations in living cells, Anal Biochem. 2001 Nov 15; 298(2):170-80.
• Zhang W, Feng JQ, Harris SE, Contag PR, Stevenson DK, Contag CH., Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression, Transgenic Res. 2001 Oct;10(5):423-34.
• Ziauddin J, Sabatini DM., Microarrays of cells expressing defined cDNAs, Nature. 2001 May 3; 411(6833):107-10.
• Zimmermann T, Rietdorf J, Pepperkok R., Spectral imaging and its applications in live cell microscopy, FEBS Lett. 2003 Jul 3; 546(1):87-92.
• Zorov DB, Kobrinsky E, Juhaszova M, Sollott SJ., Examining intracellular organelle function using fluorescent probes: from animalcules to quantum dots, Circ Res. 2004 Aug 6; 95(3):239-52.
• Zou GM, Yoder MC., Application of RNA interference to study stem cell function: current status and future perspectives, Biol Cell. 2005 Mar; 97(3):211-9.
• Zwaal RR, Ahringer J, van Luenen HG, Rushforth A, Anderson P, Plasterk RH., G proteins are required for spatial orientation of early cell cleavages in C. elegans embryos, Cell. 1996 Aug 23;86(4):619-29.

Acknowledgments

I am indebted, for their pioneering work on automated digital microscopy and High Content Screening (HCS) (1988-2001), to my former colleaguas at Janssen Pharmaceutica (1997-2001), such as Frans Cornelissen, Hugo Geerts, Jan-Mark Geusebroek, Roger Nuyens, Rony Nuydens, Luk Ver Donck and their colleaguas.

Many thanks also to the pioneers of Nanovid microscopy at Janssen Pharmaceutica, Marc De Brabander, Jan De Mey, Hugo Geerts, Marc Moeremans, Rony Nuydens and their colleagues. I also want to thank all those scientists who have helped me with general information and articles.

Copyright notice and disclaimer

My web pages represent my interests, my opinions and my ideas, not those of my employer or anyone else. I have created these web pages without any commercial goal, but solely out of personal and scientific interest. You may download, display, print and copy, any material at this website, in unaltered form only, for your personal use or for non-commercial use within your organization.
Should my web pages or portions of my web pages be used on any Internet or World Wide Web page or informational presentation, that a link back to my website (and where appropriate back to the source document) be established. I expect at least a short notice by email when you copy my web pages, or part of it for your own use.
Any information here is provided in good faith but no warranty can be made for its accuracy. As this is a work in progress, it is still incomplete and even inaccurate. Although care has been taken in preparing the information contained in my web pages, I do not and cannot guarantee the accuracy thereof. Anyone using the information does so at their own risk and shall be deemed to indemnify me from any and all injury or damage arising from such use.
To the best of my knowledge, all graphics, text and other presentations not created by me on my web pages are in the public domain and freely available from various sources on the Internet or elsewhere and/or kindly provided by the owner.
If you notice something incorrect or have any questions, send me an email.

Email: pvosta at gmail dot com

The author of this webpage is Peter Van Osta, MD.

A first draft was published on Monday, 1 December 2003 in the bionet.cellbiol newsgroup. I plan to post regular updates of this text to the bionet.cellbiol newsgroup.

Latest revision on 22 January 2011

See also

A Human Cytome Project - discussion
Drug Discovery and Development - Human Cytome Project
Human Cytome Project - How to Explore
A framework for cytome exploration